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DISSERTATION ABSTRACT 
 
Max Rodnick-Smith 
 
Doctor of Philosophy 
 
Department of Chemistry and Biochemistry 
 
June 2016 
 
Title: Mechanism of Conformational Changes of Arp2/3 Complex in the Branched  
Actin Nucleation Pathway 
 
 
Branched actin networks play an important role in cellular processes ranging from 
cell motility, endocytosis, and adhesion. The Actin-related protein 2/3 (Arp2/3) complex 
nucleates actin branches from the sides of existing actin filaments. Arp2/3 complex is 
highly regulated and requires association with ATP, actin monomers, actin filaments and 
a class of proteins called nucleation promoting factors (NPFs) to undergo an activating 
conformational change where the actin-related subunits, Arp2 and Arp3, arrange into a 
filament-like conformation that templates a new actin branch. While some progress has 
been made, the individual roles of each of these factors on the activating conformational 
change is poorly understood. In addition, it is still unclear how Arp2/3 complex is held in 
its inactive state, which is vital for understanding how activation occurs. In this 
dissertation, we dissect key interfaces in Arp2/3 complex that are responsible for holding 
it in an inactive state, and specifically evaluate the roles of ATP and WASP, the 
canonical NPF, in the activating conformational change of Arp2/3 complex.  
In chapter II, we investigated the contacts made between the Arp2 and Arp3 
subunits in their inactive state, and the role of ATP in stimulating the active 
conformation. We found that two key interfaces, the αE/αF loop in Arp2 and the C-
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terminus of Arp3, a conserved extension not present in actin, are vital for holding Arp2/3 
complex in its autoinhibited state. Evaluation of the role of ATP demonstrated that 
binding of ATP is required for the activating conformational change and displaces the 
Arp3 C-terminus, an important step in destabilization of the inactive state.  
In chapter III, we investigated the mechanism of WASP-induced conformational 
changes using an engineered crosslinking assay that only forms crosslinks when Arp2/3 
is in its active conformation. We discovered that many WASP-related proteins are 
capable of stimulating this conformational change through a mechanism that involves 
displacement of the Arp3 C-terminus. Interestingly, purified Arp2/3 complex crosslinked 
in the active conformation was hyperactive compared to WASP-mediated activation, 
demonstrating that WASP activation limits nucleation and that actin monomer delivery is 
not required for nucleation.  
This dissertation contains unpublished co-authored material.  
 
 vi 
 
 
CURRICULUM VITAE 
 
NAME OF AUTHOR:  Max Rodnick-Smith 
 
 
GRADUATE AND UNDERGRADUATE SCHOOLS ATTENDED: 
 
 University of Oregon, Eugene, OR 
 University of Texas, Austin, TX 
 University of Colorado, Boulder, CO 
 
 
 
DEGREES AWARDED: 
 
 Doctor of Philosophy, Chemistry, 2016, University of Oregon 
 Bachelor of Science, Biochemistry, 2011, University of Texas 
  
 
 
AREAS OF SPECIAL INTEREST: 
 
 Biochemistry 
 Genetics 
  
 
PROFESSIONAL EXPERIENCE: 
 
Graduate Teaching Assistant, Department of Chemistry, University of Oregon, 
Eugene, OR, 2011-2016 
 
 
PUBLICATIONS: 
 
Rodnick-Smith, M., Luan, Q., Liu, S.-L. & Nolen, B.J. (2016) The role and structural 
mechanism of WASP-triggered conformational changes in branched actin filament 
nucleation by Arp2/3 complex. PNAS Plus (submitted) 
 
Rodnick-Smith, M., Liu, S.-L., Balzer, C.J., Luan, Q., & Nolen, B.J. (2016) 
Identification of an ATP-controlled allosteric switch that controls actin filament 
nucleation by Arp2/3 complex. Nature Communications (submitted) 
 
Helgeson, L. A, Prendergast, J. G., Wagner, A. R., Rodnick-Smith, M., & Nolen, B. J. 
(2014). Interactions with actin monomers, actin filaments, and Arp2/3 complex 
define the roles of WASP family proteins and cortactin in coordinately regulating 
 vii 
 
 
branched actin networks. The Journal of Biological Chemistry, 289(42), 28856–69. 
doi:10.1074/jbc.M114.587527 
 
 
 viii 
 
 
ACKNOWLEDGMENTS 
 
First, I would like to thank my advisor, Brad Nolen, for his great mentorship 
throughout my time as a graduate student. Brad has taught me so much about how to be a 
good scientist and communicator and I believe the skills I have learned under his 
guidance will be invaluable throughout my professional career. I want to thank the other 
members of the Nolen lab, past and present, particularly Luke Helgeson and Byron 
Hetrick for their patience and mentorship in getting me started as a graduate student. I 
want to thank my committee for their support and encouragement, the University of 
Oregon Chemistry department for giving me the opportunity to pursue this degree and 
my undergraduate mentors, Dr. Karen Browning and Dr. Grace Choy for taking me on as 
an undergraduate researcher which helped solidify my passion for biochemistry. I am 
very grateful to all the friendships I have made in my time here in Eugene. All the fun 
camping trips, hikes, soccer matches, game nights, Oregon football games and car trips 
have made this some of the best years of my life and I know it will be very hard to leave 
this city. Lastly, but certainly not least, I want to thank my family for their never-ending 
love and encouragement throughout my life. The values and work ethic they have 
instilled in me has shaped who I am today, and I would not be in the position I am in 
without their support.  
 ix 
 
 
 
 
 
 
 
 
 
I dedicate this work to my mother Amie, my father Larry 
and my brother Zane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 x 
 
 
TABLE OF CONTENTS 
Chapter Page 
 
 
I. INTRODUCTION .................................................................................................... 1 
II. IDENTIFICATION OF AN ATP-CONTROLLED ALLOSTERIC SWITCH THAT 
CONTROLS ACTIN FILAMENT NUCLEATION BY ARP2/3 COMPLEX ........... 20 
 
 Introduction ............................................................................................................ 20 
 Results .................................................................................................................... 23 
 Discussion .............................................................................................................. 41 
 Materials and Methods ........................................................................................... 45 
 Bridge to Chapter III .............................................................................................. 50 
 
III. THE ROLE AND STRUCTURAL MECHANISM OF WASP-TRIGGERED 
CONFORMATIONAL CHANGES IN BRANCHED ACTIN FILAMENT 
NUCLEATION BY ARP2/3 COMPLEX ................................................................... 51 
 Introduction ............................................................................................................ 51 
 Results .................................................................................................................... 56 
 Discussion .............................................................................................................. 75 
 Bridge to Chapter IV .............................................................................................. 82 
IV. SUMMARY AND CONCLUDING REMARKS ................................................. 83 
APPENDICES ............................................................................................................. 90 
 A. SUPPLEMENTARY MATERIAL FOR CHAPTER II ................................... 90 
 B. SUPPLEMENTARY MATERIAL FOR CHAPTER III .................................. 104 
 
 
 
 xi 
 
 
Chapter                                                                                                                          Page 
REFERENCES CITED ................................................................................................ 125 
 A. CHAPTER I ...................................................................................................... 125 
 B. CHAPTER II ..................................................................................................... 133 
 C. CHAPTER III .................................................................................................... 139 
 D. APPENDIX A ................................................................................................... 143 
 E. APPENDIX B .................................................................................................... 144 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xii 
 
 
LIST OF FIGURES 
 
Figure Page 
 
CHAPTER I 
 
1. Schematic of actin nucleation and the three classes of nucleators ......................... 4 
 
2. Structure of Arp2/3 complex and conformational pathway to branch formation. . 6 
 
CHAPTER II 
 
1. Cartoon model of Arp2/3 complex activation ....................................................... 22 
 
2. The Arp3 C-terminal tail is a conserved structural feature required for autoinhibition 
of Arp2/3 complex ................................................................................................. 26 
 
3. Deletion of the Arp3 C-terminal tail causes defects in endocytic actin patches and in 
the uptake of FM4-64............................................................................................. 28 
 
4. The Arp3 C-terminus is required to prevent formation of the short pitch  
 conformation .......................................................................................................... 30 
 
5. Destabilization of the splayed Arp2-Arp3 interface stimulates the short pitch 
conformation and activates Arp2/3 complex ......................................................... 33 
 
6. The Arp3 C-terminus is an allosteric molecular switch that locks the complex in the 
inactive (splayed) conformation ............................................................................ 37 
 
7. Release of the tip of the Arp3 C-terminus from the barbed end groove stimulates 
formation of the short pitch conformation ............................................................. 40 
 
CHAPTER III 
 
1. Hypothesized CA binding mode and schematic of short pitch crosslinking assay 57 
 
2. Stimulation of the short pitch conformation is a conserved feature of WASP family 
NPFs ....................................................................................................................... 60 
 
3. CA binding to both Arp2 and Arp3 is important for stimulating the short pitch 
conformation change .............................................................................................. 63 
 
4. Locking Arp2/3 complex into the short pitch conformation bypasses the requirement 
for NPFs in activation ............................................................................................ 65 
 
 
 xiii 
 
 
Figure Page 
 
5. The short pitch crosslinked complex is more active than WASP-activated 
uncrosslinked complex........................................................................................... 67 
 
6. Residues in the C region tune are important for stimulating the short pitch 
conformational change ........................................................................................... 70 
 
7. WASP-CA fused to the C-terminus of Arp2 or Arp3 blocks binding of soluble 
WASP-VCA to the CA-fusion subunit .................................................................. 72 
 
8. WASP competes with the Arp3 C-terminus for binding the barbed end groove of 
Arp3 ....................................................................................................................... 76 
 
 
 
 1 
 
 
CHAPTER I 
 
INTRODUCTION 
 
The Actin Cytoskeleton Plays an Essential Role in Living Cells 
 The cytoskeleton is an important biological network composed of hundreds of 
individual proteins. The cytoskeleton is a dynamic protein network, of which actin is a 
central component. Actin plays a role in maintaining cell shape, sensing the surrounding 
environment, uptake and release of chemicals through endocytosis and exocytosis 
respectively, cellular motility, and transporting cellular cargo, among many other 
processes (Welch & Mullins, 2002)(Pollard & Cooper, 2009).  
Actin is a ~42kD protein that binds ATP and self-assembles into non-covalent 
polymers called filaments. Actin filaments are polar, where assembly is slow from the 
pointed or minus  (-) end and more rapid from the barbed or plus (+) end (Pollard, 1986). 
This polarity is important for many actin binding proteins, such as transport myosins V 
and VI, which “walk” along filaments toward the barbed and pointed ends of filaments, 
respectively (Li & Gundersen, 2008). Shortly after incorporation into a filament, actin 
subunits rapidly hydrolyze ATP (khydrolysis=0.3s
-1) to create ADP-Pi actin and the 
phosphate is released slowly (krelease=0.003s
-1) to form ADP actin (Fujiwara et al., 2007). 
The nucleotide state of filaments is critical for the function of the cytoskeleton, thought to 
serve as a timing mechanism to determine the age of actin filaments (Le Clainche et al., 
2003)(Martin et al., 2006)(Ingerman et al., 2013). Proteins such as ADF/cofilin recognize 
the conformational changes that occur on actin filaments during ATP hydrolysis and 
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phosphate release. Specifically ADF/cofilin binds and severs ADP-actin preferentially 
over ATP or ADP-Pi-Actin by about two-fold, enhancing filament turnover (Carlier et 
al., 2012). 
The geometry of actin networks vary depending on the function. For example, 
during muscle contraction, linear actin networks are constricted by muscle myosins, 
where the actin filaments slide past one another to generate muscle movement (Geeves & 
Holmes, 1999). In contrast, actin networks are very differnent at the leading edge of a 
lamellipodia, which is a large protrusion of the membrane important for cell motility. The 
actin networks in this structure are highly dendritic, which is important for generating the 
force necessary for cell movement (Pollard, 2007). In addition to the severing of 
filaments by ADF/cofilin mentioned above, actin networks are tightly coordinated by 
over a hundred regulatory proteins. Profilin and thymosin-β4 (Tβ4) are responsible for 
maintaining a pool of unpolymerized actin, where Tβ4 sequesters actin monomers by 
binding to both the barbed and pointed end of a single actin monomer, rendering it 
incapable of forming new filaments by preventing interactions with either ends of 
existing filaments (Mannherz & Hannappel, 2009). Profilin facilitates nucleotide 
exchange from ADP to ATP-actin and also prevents formation of new filaments, but in 
contrast to Tβ4, only binds to the barbed end of actin monomers, allowing association of 
the free pointed end to the growing barbed end of actin filaments, where profilin 
subsequently dissociates from the actin monomer (Dominguez & Holmes, 2011). In 
dense branched networks, capping proteins will bind to the growing barbed ends of 
filaments, preventing further association of new monomers and providing the structural 
rigidity needed for force generation by these networks (Edwards et al., 2014). Filaments 
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can also be cross-linked into dense arrays by, most commonly, proteins belonging to the 
calponin-homology domain family like fimbrin, α-actinin, or spectrin (Gimona et al., 
2002). Not only is controlling the various archetypes of actin networks very important, 
but controlling when and where actin polymerization is initiated is vital for cellular 
function and survival.  
 Formation of actin filaments de novo occurs through a process known as 
nucleation. During nucleation, actin monomers (globular or G-actin) must overcome a 
large thermodynamic barrier to form actin filaments (F-actin) due to the instability of 
small actin oligomers (Sept & McCammon, 2001). Despite high cellular actin 
concentrations favoring the filamentous state, kinetic modeling suggests that actin dimers 
and trimers rapidly disassemble into their monomeric forms, but once a tetramer forms, 
the actin oligo is stable and forms a filament to which new actin monomers can rapidly 
associate at a diffusion-limiting rate (Pollard, 1986)(Sept & McCammon, 2001). To 
control when and where actin filaments are generated, cells rely on three sets of actin 
“nucleators” to regulate this process; formins, tandem-WH2/V nucleators, and Arp2/3 
complex (Figure 1)(Pollard, 2007)(Campellone & Welch, 2010).   
 Formins are proteins that form homodimers and are composed of regulatory, FH1 
and FH2 domains (Pollard, 2007). Dimerization occurs through the FH2 domain, with 
each dimer binding two actin monomers, forming a donut-shaped hole that interacts with 
the barbed ends of filaments (Otomo et al., 2005). Nucleation occurs through this stable 
actin dimer, and the formin remains bound to the barbed end (Pruyne, 
2002)(Breitsprecher et al., 2012), where it recruits profiling-bound actin monomers to the 
growing barbed end through its FH1 domain (Chang et al., 1997). Tandem WH2 proteins,  
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Figure 1: Schematic of actin nucleation and the three classes of nucleators. 
A. Cartoon representation of actin nucleation in the presence and absence of an actin 
nucleator (represented by red spheres). The presence of a nucleator prevents dissociation 
of actin dimers and trimers, favoring formation of a new filament. B. Representation of 
the three classes of actin nucleators; formins, tandem WH2/V nucleators, and the Arp2/3 
complex.  
 
such as Spire and Cobl bind actin monomers through their WH2 regions (also called V or 
Verprolin-homology) and nucleate actin filaments by tethering these monomers in close 
proximity, speeding up the nucleation process (Campellone & Welch, 2010). The 
difference between tandem WH2/V nucleators and formins are that tandem WH2/V 
nucleators dissociate after nucleation, while formins will remain associated with the 
barbed end of the filament, continually adding new actin subunits and speeding up the 
elongation rate. These nucleators sometimes work in concert with formins. For example, 
Drosophila Spire has been shown to associate with the formin Cappuccino (Quinlan et 
al., 2007), where it has been proposed that one formin dimer binds two Spire molecules 
and nucleates 8 actin monomers. Spire then dissociates, thereby “handing off” the 
nucleus to Cappuccino, allowing it to processively elongate the new filament (Sitar et al., 
2011). The last class of nucleators, Arp2/3 complex will be discussed in the following 
section.  
The Arp2/3 Complex is the Key Nucleator of Actin Branches in the Cell 
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 The Actin Related Protein 2/3 (Arp2/3) complex is unique among actin nucleators 
in that it normally nucleates branched actin filaments (Amann & Pollard, 2001a)(Amann 
& Pollard, 2001b)(Egile et al., 2005)(Wagner et al., 2013). Arp2/3 complex was initially 
discovered through a profilin-affinity column of Acanthamoeba castellanii extract where 
two polypeptides (associated with five other proteins), Arp2 and Arp3, contained 
sequence homology to yeast actins, suggesting it may have a role in regulating the actin 
cytoskeleton (Machesky et al., 1994). Soon after its initial discovery, homologous 
complexes were purified from yeast (Winter et al., 1997), mammals (Welch et al., 1997) 
and Xenopus egg extracts (Ma et al., 1998). Arp2/3 complex was shown to have 
nucleation activity, however these experiments required high concentrations of complex 
(Mullins et al., 1998). Later, groups showed that proteins such as ActA from Listeria 
monocytogenes and human Scar potently induced actin polymerization combined with 
Arp2/3 complex, suggesting the complex needed to be activated in order to nucleate actin 
(Welch et al., 1998)(Machesky et al., 1999). Electron microscopy and total internal 
reflection fluoresence microscopy experiments showed that Arp2/3 complex creates actin 
branches, confirming that it was a new class of nucleator (Amann & Pollard, 
2001a)(Amann & Pollard, 2001b)(Egile et al., 2005).  
 The first crystal structure of Bos taurus Arp2/3 complex confirmed that the Arp2 
and Arp3 subunits were structurally similar to actin and the five other subunits, ARPC1-
5, form the scaffold that holds the Arp subunits in place (Figure 2A) (Robinson et al., 
2001). Interestingly, the Arp subunits were positioned in a conformation that was neither 
compatible with a long pitch (end to end) nor a short pitch (side to side) conformation 
similar to actin dimers that have been observed in structures of actin filaments. This  
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Figure 2: Structure of Arp2/3 complex and conformational pathway to branch 
formation. 
A. Crystal structure of Bos taurus Arp2/3 complex with subunits distinguished by color. 
The structure of Arp2/3 complex with GMF (not shown) was used due to disorder of 
Arp2 in other structures. B. Cartoon of the conformational pathway for branch formation. 
Arp2/3 complex in the inactive, or splayed, conformation and undergoes a 
conformational change to the short pitch conformation at a branch junction in the 
presence of ATP, WASP, actin monomers and actin filaments, although the contribution 
of each is unknown. 
 
conformation explained why Arp2/3 complex had no nucleation activity on its own and 
formed the hypothesis that the complex must undergo a large conformational change in 
order to nucleate an actin branch (Robinson et al., 2001). Since then, low-resolution 
electron microscopy reconstructions of Arp2/3 complex at a branch junction support a 
model where Arp2 and Arp3 move from the inactive (or “splayed”) conformation to a 
conformation resembling a “short pitch” actin dimer, providing the template for 
additional actin subunits to associate into a filament (Rouiller et al., 2008). Consistent 
with the hypothesis that the Arp2 and Arp3 subunits form the first two actin subunits in a 
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daughter filament, purified Schizosaccharomyces pombe Arp2/3 complex lacking the 
Arp2 subunit was unable to nucleate actin branches (Nolen & Pollard, 2008). 
Since cells require precise control of when and where new actin filaments are 
generated, it is important for cells to make sure Arp2/3 complex remains in its inactive 
state in the absence of activating factors. Yet, how Arp2/3 complex remains in its auto-
inhibited state still remains an open question. In addition to the contacts between Arp3 
and subdomain 4 of Arp2, Arp2 primarily forms contacts with the ARPC1,4,5 subunits 
while Arp3 is mostly associated with the ARPC2,3,4 subunits (Robinson et al., 2001). 
Residues in Arp2 (D’Agostino & Goode, 2005)(Martin et al., 2005), ARPC2 (Rodal et 
al., 2005), and ARPC4 (Narayanan et al., 2011) appear to have important contacts with 
neighboring subunits and mutations of these residues cause increased activity of the 
complex. While the Arp subunits are structurally homologous to actin, Arp3 harbors a 
few flexible inserts that are not present in actin that regulate the activity of the complex 
(Dalhaimer et al., 2008)(Liu et al., 2013). In addition, molecular dynamics simulations 
suggest phosphorylation of a tyrosine residue on the Arp2 subunit causes conformational 
changes of the complex, suggesting that the phosphorylation could also contribute to 
relieving autoinhibition (Narayanan et al., 2011).   
We now know that Arp2/3 complex requires interactions with ATP, actin 
monomers, actin filaments and a class of proteins called nucleation promoting factors 
(NPFs), such as ActA, Scar and WASP, in order to relieve autoinhibition and form actin 
branches (Figure 2B)(Machesky & Insall, 1998)(Machesky et al., 1999)(Dayel et al., 
2001)(Amann & Pollard, 2001b). Identifying and characterizing the various types of 
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NPFs has been an exciting development in the field of studying branch formation by 
Arp2/3 complex. 
NPFs are Composed of Diverse Classes of Proteins that Activate Arp2/3 
Complex 
The intrinsic inactivity of Arp2/3 complex is a conserved feature across many of the 
forms so far studied. Throughout evolution, many unique NPFs have arisen and can 
generally be divided into classes called Type I NPFs, Type II NPFs, and the more 
recently-discovered WISH/DIP/SPIN90 family of proteins (Pollard, 2007)(Campellone & 
Welch, 2010)(Wagner et al., 2013). Type I NPFs, the most commonly known and 
characterized being the WASP and Scar (also called WAVE) family of proteins, share a 
minimal functional region located at the C-terminus referred to as the VCA region which 
is necessary and sufficient to activate the Arp2/3 complex in vitro (Machesky et al., 
1999)(L Blanchoin et al., 2000)(Marchand et al., 2001). The VCA region is comprised of 
three discrete regions, which are called the Verprolin-homology, Central and Acidic 
regions, each conferring a unique role in the activation of Arp2/3 complex.  
The CA region interacts with the Arp2/3 complex, with the acidic region comprising 
of the bulk of the affinity, a mode dependent on a conserved tryptophan at the C-terminal 
part of the region (Marchand et al., 2001). The role of the acidic residues is less well-
defined since addition or removal of acidic residues from type I NPFs either increases or 
decreases the activity of the complex, depending on which NPF has been studied 
(Zalevsky et al., 2001)(Smith et al., 2013). The central region alone does not have 
significant affinity for Arp2/3 complex, however removal of the central region from a CA 
peptide reduced the affinity for Arp2/3 complex 5 to 8-fold (Marchand et al., 2001)(Kelly 
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et al., 2006). Despite its weak affinity, the central region has an important function in 
activation of the complex. Upon binding to the complex, it forms an amphipathic helix 
that is thought to bind the barbed end grooves of the Arp subunits and promote activation 
of the complex (Panchal et al., 2003). The central region is comprised of several 
conserved hydrophobic residues and a conserved arginine residue. Mutation of the 
hydrophobic residues had varying effects on VCA-mediated activation of Arp2/3 
complex, ranging from none to severe (Marchand et al., 2001)(Panchal et al., 2003)(Kelly 
et al., 2006). Mutation of the conserved arginine to lysine in WASP (R477K) has been 
observed in patients with Wiskott-Aldrich Syndrome (the disease from which WASP gets 
its name)(Derry et al., 1995) and has diminished activity in polymerization assays 
(Marchand et al., 2001)(Panchal et al., 2003).  
The V region is the defining characteristic of type I NPFs. The V region forms an α-
helix that interacts with the barbed end groove of actin monomers (Chereau et al., 2005), 
and delivers them to Arp2/3 complex, which is thought to stabilize the actin nucleus and 
allow faster branch formation (Higgs et al., 1999). This activity is vital for Arp2/3 
complex activity, as the CA region alone provides little to no activation of the complex 
(Marchand et al., 2001)(Kelly et al., 2006). Interestingly, the number of V regions in type 
I NPFs varies to some degree, with the majority containing one V region N-terminal to 
the CA region, however some NPFs contain multiple V regions like N-WASP and 
WHAMM (two V regions) or JMY (three V regions)(Zuchero et al., 2009)(Dominguez, 
2009)(Campellone & Welch, 2010). Increasing the number of V regions is thought to 
speed up actin nucleation by stabilizing larger actin oligomers, which is thought to be the 
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mechanism of tandem WH2 nucleators such as Spire, which nucleates linear actin 
filaments through four consecutive WH2 regions (Quinlan et al., 2005)(Sitar et al., 2011).  
Type II NPFs are characterized by their ability to bind actin filaments, rather than 
monomers (Goley & Welch, 2006). All type II NPFs contain an acidic region that is 
capable of binding Arp2/3 complex, however some fungal type II NPFs, such as coronin, 
Myo3p and Myo5p also contain C regions (Evangelista et al., 2000)(Humphries et al., 
2002)(Liu et al., 2011). One of the most well characterized type II NPFs is cortactin 
(Uruno et al., 2001)(Uruno et al., 2003)(Helgeson & Nolen, 2013)(Helgeson et al., 2014), 
which is present in metazoans and localizes to many Arp2/3 complex-containing actin 
networks, most notably invadopodia which are protrusions of the membrane often 
associated with cancer cells that are involved in degradation of the extracellular matrix 
(Ayala et al., 2008). The mechanism for activation by type II NPFs varies. Due to their 
actin filament binding properties, type II NPFs are believed to activate Arp2/3 complex 
by recruiting them to the sides of filaments (Goley & Welch, 2006). However, 
experiments suggest that by themselves, type II NPFs are weak activators of Arp2/3 
complex. Cortactin fails to activate Arp2/3 complex to a significant degree by itself 
(Uruno et al., 2001)(Uruno et al., 2003)(Helgeson & Nolen, 2013)(Helgeson et al., 2014). 
Yeast coronin produces some activation at low concentrations, but inhibits at high 
concentrations, possibly due to saturating the sides of filaments, preventing Arp2/3 
complex from binding (Humphries et al., 2002)(Liu et al., 2011). Yeast proteins Myo5p 
and Abp1 either fail to or weakly produce any activation of Arp2/3 complex (Sun et al., 
2006)(Goode et al., 2001). Despite this weak activity, type II NPFs can often indirectly 
activate the complex. While cortactin is unable to activate the complex on its own, potent 
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synergistic activation of Arp2/3 complex is achieved upon addition of dimeric NPF 
constructs due to cortactin enhancing the slow dissociation step of these NPFs (Uruno et 
al., 2001)(Uruno et al., 2003)(Helgeson & Nolen, 2013)(Helgeson et al., 2014). Yeast 
myosins also activate the complex by binding to verprolin, which recruits actin 
monomers to the complex, allowing activation. Consistent with the inability of type II 
NPFs to directly recruit actin monomers, addition of V regions to cortactin caused 
activation of Arp2/3 complex, although not as strongly as VCA (Helgeson et al., 2014).  
The WISH/DIP/SPIN90 family of proteins has only been recently classified as an 
activator of Arp2/3 complex, however this family is very unique among NPFs in that 
these proteins recruit Arp2/3 complex to generate linear filaments (Wagner et al., 2013). 
Unlike type I or type II NPFs, these proteins bind neither actin filaments nor monomers, 
and lack the canonical acidic region containing the conserved tryptophan thought to be 
required for all NPFs (Wagner et al., 2013). Instead, WISH/DIP/SPIN90 proteins utilize a 
leucine-rich domain that has not been observed in other NPFs, making this family of 
proteins an intriguing target for further mechanistic studies.  
In addition to all of the classes of NPFs described among eukaryotes, bacterial 
pathogens have developed novel NPFs of their own in order to hijack their host’s 
cytoskeleton in order to promote movement within in the cell, including, but not limited 
to, ActA from Listeria monocytogenes (Welch et al., 1998) and VopL from Vibrio 
parahaemolyticus (Liverman et al., 2007). Due to the vast variety of NPFs, determining 
the mechanisms of how these proteins coordinate the regulation of branched actin 
networks is an important and challenging goal for understanding cytoskeletal dynamics. 
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Individual Roles of ATP, WASP, Actin Monomers and Actin Filaments in the 
Branched Actin Nucleation Pathway 
 Although it is known that ATP, WASP, monomers and filaments are required to 
form actin branches, the specific contributions of each are not well understood. ATP 
hydrolysis by the Arp subunits, like with actin, provides a timing mechanism to 
determine the age of actin branches, aiding in actin branch disassembly (Le Clainche et 
al., 2003)(Martin et al., 2006)(Ingerman et al., 2013). Hydrolysis of ATP in actin 
promotes disassembly by the actin filament-severing protein cofilin (Blanchoin et al., 
2000). Similarly, the ADF/cofilin homolog GMF, which severs filaments at the branch 
junction rather than the sides of the filament, possibly acts through an analogous 
mechanism with Arp2 (Gandhi et al., 2010)(Luan & Nolen, 2013).  
 In addition to providing a timing mechanism, ATP binding to Arp2/3 complex is 
important for initial branch formation. In crystal structures of Arp2/3 complex, the 
nucleotide-free state shows the nucleotide cleft in Arp3 to be in an open conformation 
and upon nucleotide binding, constricts into a more closed form (Robinson et al., 
2001)(Nolen et al., 2004). Subdomains 1 and 2 of Arp2 are disordered in these structures, 
however a recent structure of Arp2/3 complex with ATP and GMF bound caused 
ordering of these domains and the nucleotide cleft of Arp2 was observed to be closed 
(Luan & Nolen, 2013). The effect of ATP binding on the short pitch conformation was 
investigated with labeled ARPC1 and ARPC3 subunits and caused an increase in FRET, 
but due to the low resolution of this technique, the exact structural changes are unclear 
(Goley et al., 2004). In molecular dynamics simulations, ATP binding caused release of 
the Arp3 C-terminus from its barbed end groove, which is thought to be an important 
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regulatory element in Arp2/3 complex activation and could explain the conformational 
changes observed in the FRET experiments (Dalhaimer et al., 2008). Consistent with 
these simulations, the C-terminus becomes more disordered in crystal structures when 
ATP and other nucleotides are bound (Robinson et al., 2001)(Nolen et al., 2004)(Nolen & 
Pollard, 2007).  
 Unlike ATP, much less is known of the nature and effects of WASP binding to 
the complex. Experiments using analytical ultracentrifugation (Padrick et al., 
2011)(Hetrick et al., 2013) and isothermal titration calorimetry (Ti et al., 
2011)(Boczkowska et al., 2014) have supported binding of two VCA molecules to 
Arp2/3 complex. Additionally, dimeric VCA constructs bind the complex with ~100-180-
fold higher affinity (Padrick et al., 2008). WASP-related proteins have not been shown to 
dimerize in isolation, however they are believed to act as oligomers in cells due to 
clustering on the plasma membrane (Padrick et al., 2008)(Gohl et al., 2010)(Suetsugu, 
2013). Chemical crosslinking studies have suggested that one of the VCA peptides binds 
to Arp3, while the other spans Arp2 and ARPC1 (Kreishman-Deitrick et al., 
2005)(Padrick et al., 2011)(Liu et al., 2011)(Ti et al., 2011). The acidic region is believed 
to bind to Arp3 between subdomains 3 and 4, based on crystal structures containing 
Arp2/3 and WASP showing weak electron density in this region (Ti et al., 
2011)(Jurgenson & Pollard, 2015), while the other acidic region is believed to bind 
ARPC1, since this subunit binds CA in isolation (Pan et al., 2004). The ITC experiments 
have shown that the two binding sites have roughly a 9 to 25-fold difference in affinity, 
suggesting that there might be an importance of one binding site over the other (Ti et al., 
2011)(Boczkowska et al., 2014). Indeed, there has been some debate as to which binding 
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site is first targeted by VCA. Low resolution structures of VCA and VCA crosslinked to 
actin monomers bound to the complex have suggested that the first binding site is on 
Arp3 or Arp2, respectively (Xu et al., 2012)(Boczkowska et al., 2008), although it is 
possible that the preference of binding for the high affinity site can be influenced by the 
presence of actin monomers.  
 While the exact effects of the individual WASP binding sites have not been fully 
elucidated, studies have supported a model where WASP stimulates a conformational 
change in Arp2/3 complex that adopts a more “filament-like” conformation. Addition of 
WASP caused a large increase in the FRET assay described above (Goley et al., 2004) 
and single-molecule particle EM reconstructions show that addition of WASP to Arp2/3 
complex caused the complex to adopt a more “closed” conformation (Rodal et al., 2005), 
suggesting WASP stimulates the short pitch conformation. Lastly, engineered cysteine 
mutations in the Arp2 and Arp3 subunits that only crosslink the two subunits together in 
the expected “short pitch” conformation in the presence of BMOE, an ~8 Å crosslinker, 
show an increase in crosslinking upon the addition of N-WASP-VCA, an effect that is 
reduced upon addition of the Arp2/3 complex inhibitor CK-666, demonstrating that this 
inhibitor blocks the activating conformational change induced by WASP (Hetrick et al., 
2013). Determining precisely how WASP induces this conformational change is an 
important unanswered question in the field.  
 The role of VCA-recruited actin monomers has long been assumed to stabilize the 
nascent nucleus, speeding up the slow nucleation step (Higgs et al., 1999). Like VCA 
binding, the importance of delivering actin monomers to either the Arp2 or the Arp3 site 
is still uncertain. A peptide-linked diVCA construct did not show any preference in 
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binding of the N or C-terminal VCA portion, however in the presence of actin monomers, 
displayed asymmetric binding (Padrick et al., 2011). Removal of the C-terminal V region, 
which preferentially delivers actin monomers to the Arp3 site, caused a more dramatic 
loss of VCA activity versus removal of the N-terminal V region, suggesting delivery of 
monomers to the Arp3 site is more important (Padrick et al., 2011). However, it is 
unclear if the asymmetric binding still holds in the absence of actin monomers at these 
sites. A low resolution small-angle X-ray scattering (SAXS) structure suggests that a 
single actin monomer crosslinked to VCA puts the actin monomer at the barbed end of 
Arp2, however this structure could not discern if Arp2/3 complex was in the splayed or 
short pitch conformation (Boczkowska et al., 2008). Additional evidence that the first 
actin monomer was delivered to Arp2 came from ITC experiments demonstrating that 
GMF, which binds to the barbed end of Arp2 (Luan & Nolen, 2013), did not bind to a 
1:1:1 Actin:VCA:Arp2/3 complex (Boczkowska et al., 2014). While the effects of actin 
monomer delivery to the Arp2 versus the Arp3 site are still unclear, recent experiments 
using the dual-cysteine crosslinking assay revealed that addition of actin monomers with 
WASP to the reaction caused an increase in crosslinking over WASP alone, 
demonstrating that actin monomers aid in stimulation of the short pitch conformation 
(Hetrick et al., 2013). This result was surprising because it suggests that WASP alone 
cannot fully populate the short pitch conformation, and that actin monomer delivery is 
required for the maximal stability of the short pitch conformation. This experiment was 
conducted under saturating VCA+actin conditions, so the individual role of delivery to 
Arp2 versus Arp3 is still unclear. A structural argument for the importance of delivery of 
actin to Arp3 can be made. The inactive structure of Arp2/3 complex shows that the 
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barbed end of Arp3 is blocked by Arp2 (Robinson et al., 2001), suggesting that an actin 
monomer delivered to this site would prevent Arp2 from transitioning back to the splayed 
conformation. Testing this hypothesis will be important for understanding the role of 
monomer recruitment in Arp2/3 complex activation.  
 Since Arp2/3 complex is a branched actin nucleator, the field has assumed that 
actin filaments cooperate with WASP and actin monomers to stabilize the short pitch 
conformation, although this role has not been directly tested. The dual-cysteine 
crosslinking assays suggest that WASP and actin monomers alone are capable of potently 
stimulating the short pitch conformation, suggesting the role of actin filaments could be 
more nuanced (Hetrick et al., 2013). WASP and actin monomers appear to stabilize the 
short pitch conformation, yet filaments are required for branch formation. Mutations of 
the predicted actin filament binding interface, as determined by molecular docking 
simulations, reduced the activity of Arp2/3 complex in pyrene actin polymerization 
assays and affected the stability of branches that actually formed (Goley et al., 2010). 
These mutations did not affect ATP and CA-induced conformational changes as 
measured by FRET, indicating their role is for the binding and stability of Arp2/3 
complex to actin filaments (Goley et al., 2010).  
One possible clue for the role of filaments comes from a model of an actin filament 
generated by x-ray fiber diffraction (Oda et al., 2009). In crystal structures of actin 
monomers alone, the nucleotide cleft in subdomains 2 and 4 of actin are closed with the 
two regions in a “twisted” conformation (Kabsch et al., 1990). In the F-actin model, the 
nucleotide cleft remains closed, but the subdomains untwist into a more “flattened” 
conformation (Oda et al., 2009). Indeed, in the EM reconstruction of Arp2/3 complex at 
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the branch junction, the Arp subunits appear to be in a more closed state, presumably the 
“flattened” conformation (Rouiller et al., 2008). This flattened conformational change is 
expected to initiate ATP hydrolysis as actin monomers are incorporated into the 
elongating filament (Oda et al., 2009). In one study, WASP and actin monomers alone 
were not able to stimulate hydrolysis of ATP in Arp2, however once WASP, monomers 
and filaments were mixed together, hydrolysis did occur (Dayel & Mullins, 2004). One 
interpretation of this result could be that WASP and actin monomers stimulate the short 
pitch conformation, but that this is not enough to nucleate a new filament. Once this 
assembly binds to a mother filament, the flattened conformation in Arp2 and Arp3 is 
stimulated and then an actin branch can form. Due to the lack of evidence for the role of 
actin filaments, testing if actin filaments stimulate flattening or other important steps in 
the pathway is essential to understanding why Arp2/3 complex exclusively forms 
branched actin networks. 
In chapter II, we investigated how Arp2/3 complex is held inactive in the absence of 
activating factors. From previously published high resolution crystal structures (Robinson 
et al., 2001)(Nolen et al., 2004)(Nolen & Pollard, 2007) and molecular dynamics 
simulations (Dalhaimer et al., 2008), we hypothesized that the Arp3 C-terminal tail plays 
an important role in stabilizing the inactive state, with the N-terminal portion (or “base”) 
forming contacts with subdomain 4 of Arp2 and the C-terminal portion (or “tip”) wedged 
in the barbed end groove of Arp3. We found that removal of the C-terminal region in S. 
pombe and S. cerevisiae Arp2/3 complexes caused NPF-independent hyperactivity and 
affected actin patch dynamics in vivo. We show that removal of the C-terminus causes a 
potent increase in formation of short pitch crosslinking, suggesting the Arp3ΔC complex 
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more closely resembles the active conformation. Mutational analysis of subdomain 4 of 
Arp2, specifically the αE/αF loop, shows that this region provides important contacts in 
the inactive conformation, as these mutants displayed NPF-independent activity in actin 
polymerization and crosslinking assays. Since crystal structures showed that ATP causes 
an allosteric effect, where closing of the Arp3 nucleotide cleft correlates with disorder of 
the C-terminal tail, we hypothesized that ATP is required for stimulation of the short 
pitch conformation. Using mutations of the nucleotide binding clefts of Arp2 and Arp3, 
we show that ATP binding is required for crosslinking, demonstrating why ATP is 
required for activation. Lastly, we show that destabilization of the tip of the C-terminal 
tail also causes NPF-independent hyperactivity, supporting a “tail release” model where 
ATP binding causes release of the tip of the tail from the barbed end groove of Arp3 
causing destabilization between the base of the tail and Arp2, thereby stimulating the 
short pitch conformation.  
In chapter III, we specifically investigated the role of WASP proteins in the short 
pitch conformational change. Using the crosslinking assay, we demonstrate that 
stimulation of the short pitch conformation is a conserved feature of WASP-related 
proteins. Mutational analysis of N-WASP shows that while residues in both the C and A 
regions are important for activity in polymerization assays, only residues in the C region 
are important for stimulation of the short pitch conformation, as demonstrated by 
crosslinking. To determine the importance of binding of WASP either the Arp2 or Arp3 
site, we use WASP-Arp chimeras where the CA is fused to the C-terminus of either Arp2 
or Arp3 to demonstrate that binding of WASP to both sites is important for full 
stimulation of the short pitch conformation. To determine the precise role of the short 
 19 
 
 
pitch conformation on branch formation, we purified Arp2/3 complex crosslinked into the 
short pitch conformation and, remarkably, found that it is much more active compared to 
WASP-activated complex. We show that this is likely due to WASP release limiting 
nucleation rates, as CA inhibited the short pitch crosslinked complex in polymerization 
assays. Finally, using the Arp3ΔC strain described in chapter II, we show that binding of 
WASP’s C-region to the barbed end groove of Arp3 competes with the C-terminal tail, 
supporting our “tail release” model where WASP and ATP cooperate to displace the 
Arp3 C-terminal tail to promote the short pitch conformation.  
The work presented in chapter II has been submitted to the journal Nature 
Communications and was coauthored with Su-Ling Liu, Connor J. Balzer, Qing Luan and 
Brad J. Nolen. The work presented in chapter III has been submitted to the journal PNAS 
and was coauthored with Qing Luan, Su-Ling Liu and Brad J. Nolen.  
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CHAPTER II 
 
IDENTIFICATION OF AN ATP-CONTROLLED ALLOSTERIC SWITCH THAT 
CONTROLS ACTIN FILAMENT NUCLEATION BY ARP2/3 COMPLEX. 
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INTRODUCTION 
Arp2/3 (Actin-related protein 2/3) complex is a seven-subunit protein assembly 
that plays a key role in regulating the actin cytoskeleton. By nucleating branched actin 
filaments in response to cellular signals, it controls the assembly of dendritic actin 
networks required for a broad range of cellular processes, including endocytosis, 
protrusion of invadopodia and lamellipodia, and positioning of the meiotic spindles1-3. In 
the absence of activating factors, Arp2/3 complex is held in an inactive or low activity 
state. Activation typically requires interactions with several activating factors, including 
preformed actin filaments, actin monomers, ATP, and a class of proteins called 
nucleation promoting factors (NPFs)4-10. The nucleation activity of Arp2/3 complex must 
be tightly regulated by these factors for cells to properly control the dynamics and 
architectures of actin networks11-13. Despite the importance of ensuring that the complex 
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does not nucleate filaments in the absence of activators, the molecular basis by which the 
complex is held in an autoinhibited state is not understood.  
Several high-resolution structures of autoinhibited/inactive Arp2/3 complex are 
available14-17. In this conformation, the two actin-related subunits in the complex, Arp2 
and Arp3, align roughly end-to-end in a conformation referred to as “splayed” (Fig. 1). 
Activation is thought to require a substantial structural change in which Arp2 moves ~20 
Å into position side-by-side with Arp3, creating an Arp2-Arp3 “short pitch” heterodimer 
that mimics two consecutive actin monomers within a filament. The short pitch 
conformation is hypothesized to provide the nucleus to template a new filament14. While 
this hypothesis has never been directly tested, several lines of evidence indicate that 
activating factors stimulate movement of Arp2 and Arp3 into the short pitch 
conformation, suggesting this conformational change may be a key activation step7,18-22. 
Therefore, controlling the conformational switch from the splayed to the short pitch state 
could be a critical aspect of Arp2/3 complex regulation. However, despite the availability 
of high-resolution structures of the inactive complex and several mutational studies, the 
structural features of the complex that stabilize the splayed/autoinhibited state in the 
absence of activators have yet to be clearly identified. Activating mutations on four 
Arp2/3 complex subunits (Arp2, Arp3, ARPC2, and ARPC4) have been identified either 
in screens or in targeted mutational analysis, but the mechanism by which these 
mutations influence the conformation of the complex is unknown7,13,20,23-26. Identification 
and structural dissection of autoinhibitory features would not only reveal how nucleation 
is prevented in the absence of activating factors, but would provide a framework for 
understanding how activators stimulate nucleation. 
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Figure 1 | Cartoon model of Arp2/3 complex activation.  
Activation of Arp2/3 complex is thought to require movement of the actin-related 
subunits Arp2 and Arp3 from an inactive “splayed” conformation to an active 
conformation that mimics a filament-like short pitch actin dimer. ATP, actin monomers, 
actin filaments, and an NPF protein are typically required for activation. 
 
Multiple inputs (NPFs, actin monomers, actin filaments and ATP) are required for 
activation of the complex. Mounting evidence indicates that each of these inputs plays an 
important role in regulating the dynamics and architectures of Arp2/3-nucleated actin 
networks in vivo4,10,27-29. For instance, NPFs such as the WASP family proteins link 
Arp2/3 complex to cellular signaling pathways, while the requirement for preformed 
filaments ensures that the complex creates exclusively branched actin filaments4,10. 
Likewise, bound ATP provides a built-in timer that controls branch lifetimes, since 
hydrolysis of ATP occurs on the complex following nucleation and stimulates 
debranching28,30,31. Like WASP, ATP binding causes conformational changes in the 
complex, but how these changes are linked to activation is not known. In x-ray crystal 
structures, ATP binding causes the nucleotide cleft of Arp3 to close, moving subdomain 
4 of Arp3 closer to subdomain 215,16. ATP binding increases FRET in Arp2/3 complex 
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tagged with fluorescent proteins, providing additional evidence for ATP-induced 
structural changes21. A precise understanding of these changes and how they are linked to 
activation is critical, both to determine how the ATP-binding requirement is structurally 
encoded into the branching nucleation mechanism and to uncover the molecular bases for 
regulating branched actin network dynamics. 
Here we identify interactions at the Arp2-Arp3 splayed interface as key 
autoinhibitory features of the Arp2/3 complex. We show that destabilizing this interface 
stimulates population of the short pitch conformation and activates Arp2/3 complex 
nucleation activity. We identify the Arp3 C-terminal tail as a switchable molecular 
element that controls the activity of the complex in vitro and in vivo by controlling the 
stability of the Arp2-Arp3 splayed interface. Specifically, our data indicate that 
engagement of the Arp3 C-terminal tail with the Arp3 barbed end groove helps hold the 
complex in the inactive splayed conformation, while release of the tail destabilizes the 
splayed interface to stimulate the short pitch conformation.  ATP binding stimulates the 
short pitch conformation, likely through an allosteric connection between the nucleotide 
binding cleft and the barbed end groove that triggers release of the Arp3 C-terminus. 
Therefore, this work reveals a molecular mechanism by which ATP contributes to 
activation and provides a structural framework to understand how activators of Arp2/3 
complex can relieve autoinhibition to activate branching nucleation. 
 
RESULTS 
The C-terminus of Arp3 is required to keep Arp2/3 complex inactive in the absence 
of activators 
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Both Arp2 and Arp3 contain several conserved inserts/extensions relative to actin, 
suggesting that in addition to mimicking actin during nucleation, the actin-related 
subunits play additional structural roles in the function of the complex24,32. Consistent 
with this hypothesis, we recently discovered two insertions within the Arp3 subunit that 
harbor complex-specific functions, one in controlling interactions with actin filaments 
and another in stabilizing attachment of a non-actin related subunit to the complex24. 
These observations led us to wonder if other insertions/extensions could be directly 
involved in the response of the complex to its regulators. Our analysis led to one 
promising candidate, a conserved extension in Arp3 termed the C-terminal tail, which 
wedges into a cleft between subdomains 1 and 3 called the barbed end groove (Fig. 2a). 
The surface of the barbed end groove is largely hydrophobic, and two conserved non-
polar residues within the Arp3 C-terminus pin it into the groove in some structures (Fig. 
2b)14,16. Molecular dynamics simulations suggested the engagement of the C-terminal tail 
with the barbed end groove could allosterically influence the conformation of the Arp3 
nucleotide binding cleft33, so we reasoned that the tail could be important for controlling 
the conformation and activity of the complex. To test this, we created a budding yeast 
strain expressing an arp3 mutant (arp3ΔC) lacking 10 residues from its C-terminus as its 
sole copy of Arp3. The Arp3ΔC complex was purified from budding yeast and its activity 
measured in a pyrene actin polymerization assay (Fig. 2c,d, Fig. S1). The C-terminal 
truncation potently increased the NPF-independent activity of Arp2/3 complex. In 
reactions containing 50 nM Arp2/3 complex the maximum polymerization rate increased 
~20-fold upon deletion of the Arp3 C-terminus. These data demonstrate that the Arp3 C-
terminus plays a critical role in keeping the complex inactive in the absence of activators. 
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To determine if the autoinhibitory function of the Arp3 C-terminus is conserved, we 
truncated the homologous resides from the C-terminus of S. pombe Arp3. To accomplish 
this, we used the homologous recombination method of Bahler et. al., to introduce a 
premature stop codon in ARP3 at its endogenous locus in S. pombe34. We then purified 
and assayed the mutant complex. As observed with budding yeast Arp3, deletion of the 
C-terminus of S. pombe Arp3 increased the NPF-independent activity of the complex 
(Fig. 2e,f). In the absence of nucleation promoting factors, 200 nM S. pombe Arp3ΔC 
increased the maximum polymerization rate almost two-fold over actin alone in a pyrene 
actin polymerization assay. Under the same conditions, wild-type Arp2/3 complex 
showed only a ~16% increase in the maximum polymerization rate over reactions with 
actin alone. These data demonstrate that the C-terminus of Arp3 has a conserved role in 
autoinhibiting Arp2/3 complex.  
 
The C-terminus of Arp3 is required for proper assembly and function of endocytic 
actin structures in yeast  
We next asked if deletion of the C-terminus has functional consequences in vivo. 
Specifically, we tested whether Arp3 C-terminal tail deletion influences the assembly or 
dynamics of S. pombe actin patches, cortical actin networks required for plasma 
membrane invagination during endocytosis7,23,35-38. To monitor actin patch dynamics, we 
used GFP-tagged Fim1, an actin crosslinking protein that binds actin filaments in the 
patches and shows the same accumulation and disassembly kinetics as actin39,40. Actin 
patches in the arp3ΔC strain were similar in quantity and overall appearance to wild type 
patches (Fig. 3a,b). In wild type cells, the Fim1-GFP signal typically accumulated at the  
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Figure 2 | The Arp3 C-terminal tail is a conserved structural feature required for 
autoinhibition of Arp2/3 complex.  
(a) Ribbon diagram of Arp3 from crystal structure of Bos taurus Arp2/3 complex (1K8K) 
showing the position of the Arp3 C-terminus (yellow)14. Subdomains 1-4 are numbered 
and the ATP binding site in Arp3 is indicated with cyan circle. The base and tip of the 
Arp3 C-terminus are highlighted in pink and green, respectively. (b) Sequence alignment 
of the C-terminus of Arp3 from diverse species. At: Arabidopsis thalania; Ce: 
Caenorhabditis elegans; Dm: Drosophila melanogaster; Hs: Homo sapiens; Dr: Danio 
rerio; Dd: Dictyostelium discoideum; Sc: Saccharomyces cerevisiae; Sp: 
Schizosaccharomyces pombe; act: rabbit skeletal muscle actin. Residues underlined and 
in red are deleted in Arp3ΔC mutants. Cyan boxed residues are conserved in Arp3 
sequences. Asterisks mark conserved hydrophobic residues that pin the C-terminal tail 
into the barbed end groove in some crystal structures. (c) Time course of pyrene actin 
polymerization with 3 μM 15 % pyrene-labeled actin showing constitutive activity of 
Arp3ΔC mutant compared to wild-type S. cerevisae (Sc)Arp2/3 complexes. (d) 
Maximum polymerization rate versus concentration of wild-type or Arp3ΔC S. cerevisiae 
complex for conditions described in C. (e) Time courses of pyrene actin polymerization 
as measured in (b), but with S. pombe (Sp)Arp2/3 complexes. (f) Maximum 
polymerization rate versus concentration of wild-type or Arp3ΔC S. pombe complexes 
for conditions described in (e). 
 
cortex and then moved inward as it disappeared, consistent with previous studies41,42. 
Importantly, actin patches in the arp3ΔC strain frequently failed to internalize, with only 
51 % of actin patches (n = 114) moving off of the cortex compared to 76 % of the patches 
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tracked in wild type cells (n = 113, Fig. 3c). Actin patches in the arp3ΔC strain also had 
longer lifetimes than wild type patches (Fig. 3d, Supplementary Movie 1 and 2). To 
determine whether the increased lifetimes were caused by decreased patch assembly or 
disassembly rates, we measured Fim1-GFP intensity throughout the patch lifetime in both 
wild type and Arp3ΔC mutant cells.  Both assembly and disassembly were slowed, and 
the total intensity of Fim1-GFP was less in the mutant (Fig. 3e). This result was 
unexpected, since increases in Arp2/3 complex activity might be expected to accelerate 
actin patch assembly (see discussion). We next asked if the actin defects influenced 
endocytosis by pulsing cells with the lipophilic dye FM4-64. In wild type cells, the dye 
was immediately internalized from the plasma membrane, and stained endosomes and 
other internal membranes even at the first imaging time point, similar to previous 
reports24 (Fig. 3f). In contrast, uptake was delayed in the arp3ΔC strain, with strong 
FM4-64 staining of the plasma membrane 5 min after the initial pulse. By comparison, 
the delay was more pronounced in a wsp1Δ strain43, where strong staining was visible at 
the plasma membrane up to 20 min after the pulse. The observed defects in both actin 
patch dynamics and endocytosis indicate that the C-terminal tail of Arp3 is required to 
properly regulate Arp2/3 complex in vivo.  
 
The Arp3 C-terminus is required to prevent formation of the Arp2-Arp3 short pitch 
dimer  
Our data show that the Arp3 C-terminal tail plays a critical role in keeping the 
complex inactive in the absence of activators. We analyzed the available x-ray crystal 
structures to determine how the tail could influence activity. The N-terminal portion of  
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Figure 3 | Deletion of the Arp3 C-terminal tail causes defects in endocytic actin 
patches and in the uptake of FM4-64.  
(a) Spinning disk confocal fluorescence micrographs of wild type and mutant S. pombe 
cells expressing Fim1-GFP. Images are taken thorough the middle of the cells. (b) 
Average number of patches per cell (n≥50 cells). Error bars show standard error. (c) 
Kymographs of four actin patches for wild type and Arp3ΔC strain. (d) Average patch 
lifetime for wild type and Arp3ΔC strain. Error bars show standard error. (e) 
Quantification of Fim1-GFP intensity in wt and Arp3ΔC S. pombe cells. Data show 
average intensity and standard deviation from measurements of patches from wt (n=30 
patches) and Arp3ΔC (n=30) strains, respectively. The zero time point was taken to be 
the frame of maximum Fim1-GFP intensity during the lifetime of each patch. (f) FM4-64 
endocytosis assay showing that Arp3ΔC strain exhibits slowed dye uptake compared to 
the wild type strain.  
 
 
the tail, which we refer to as the “base” of the tail, wraps around the bottom of 
subdomain 1, fills the back end of the barbed end groove, and directly contacts 
subdomain 4 of Arp2 at the splayed interface14-16. The C-terminal end of the tail, which 
we will refer to as the “tip”, wedges into the front portion of the barbed end groove and is 
pinned into position by L445 and F446 (Fig. 4a). In some x-ray crystal structures, the tip 
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engages the groove while in others, it is disengaged and disordered14-16. Because the base 
of the Arp3 C-terminal tail occupies a critical position at the Arp2-Arp3 splayed interface 
and the tip adopts multiple conformational states, we hypothesized that the Arp3 C-
terminus could be a switchable structural element that allows activating factors to 
influence the stability of the Arp2-Arp3 splayed interface.  
To test this, we first asked if the Arp3 C-terminal tail is required to hold the 
complex in the splayed conformation. We used a previously described crosslinking assay 
in which engineered cysteines on Arp2 and Arp3 can be crosslinked by the 8 Å 
crosslinker bismaleimidoethane (BMOE) only when the complex is in the short pitch 
conformation22 (Fig. 4b). The Arp3 C-terminal deletion is not predicted to significantly 
influence either the solvent accessibility or the pKa of the engineered cysteine residues, 
ensuring that changes in short pitch crosslinking efficiency are due to the conformational 
change and not the chemical reactivity of the thiol groups (Supplementary Table 1).  
Deletion of the Arp3 C-terminal tail in the context of the dual cysteine S. cerevisiae 
Arp2/3 complex potently stimulated crosslinking between the engineered cysteines (Fig. 
4c,d). A thirty second reaction with 25 μM BMOE, 200 μM ATP and no NPF yielded 31 
± 6 % crosslinking with the Arp3ΔC complex, while a negligible amount of the wild type 
complex was crosslinked under the same conditions. These data indicate that the C-
terminal tail of Arp3 is a critical autoinhibitory structural feature that prevents the 
complex from adopting the short pitch conformation in the absence of WASP proteins.  
We note that analysis with the program X-walk showed that minimal crosslinking length 
required to bond the engineered cysteines when the complex is in the short pitch 
conformation (Cβ to Cβ) is between 8.0 and 11.3 Å, very close to the maximum expected  
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Figure 4 | The Arp3 C-terminus is required to prevent formation of the short pitch 
conformation.  
(a) Surface representation of BtArp2/3 complex (4JD2) showing the barbed end of Arp3, 
the barbed end groove and Arp3 C-terminal tail (yellow stick representation). Residues in 
Arp3 are colored according to hydrophobicity, with polar residues orange and non-polar 
residues grey. Residues are labeled based on the S. cerevisiae Arp2/3 complex sequences. 
(b) Ribbon diagrams of Arp2 and Arp3 showing the position of engineered cysteines 
(Arp3(L155C), Arp2(R198C)) in the splayed and short pitch conformations and the 
structure of the chemical crosslinker (BMOE) used in the short pitch crosslinking assay. 
Structure 4JD2 was used to make both panels. In the right panel, the Oda, et. al. actin 
filament structure was used to move Arp2 into the short pitch conformation70. The 
solvent accessible crosslinking distance between engineered cysteines is 32.5 Å in the 
splayed conformation, and ranges from ~8-11.3 Å in different models of the short pitch 
conformation (see Fig S3) 44. (c) Anti-Arp3 western blot of 1 minute crosslinking 
reactions containing 1 μM wild type (wt) or Arp3ΔC ScArp2/3 complexes in 200 μM 
ATP, 1 mM MgCl2, 50 mM KCl, 20 mM Imidazole pH 7.0, and 1 mM EGTA. Both 
complexes harbor the dual engineered cysteine residues. The Arp3ΔC complex also 
contains the C426A mutation to eliminate the non-short pitch crosslinking product (see 
Fig. 7).  (d) Quantification of reaction described in panel (c). Error bars show standard 
error for three reactions. 
 
 
crosslinking distance of BMOE (~8 Å from sulfur to sulfur) 44. Therefore, the crosslinked 
complex is held in or very near the short pitch conformation. For simplicity, we refer to 
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the crosslinked complex as being in the short pitch conformation in the sections that 
follow, though it is important to note that we cannot currently eliminate the possibility 
that Arp2 and Arp3 could deviate somewhat from a perfect filament-like arrangement and 
still form the engineered crosslink.  
 
Destabilization of the splayed Arp2-Arp3 interface activates Arp2/3 complex 
The base of the Arp3 C-terminal tail directly contacts Arp2 at the splayed 
interface, suggesting the tail prevents adoption of the short pitch conformation by 
stabilizing the splayed conformation (Fig. 4a). However, some residues in the Arp3 C-
terminal tail are near the Arp2-Arp3 short pitch interface in the electron tomography 
model of a branch junction45 (Fig. S2), so it is also possible that the C-terminal truncation 
influences the conformation of the complex by stabilizing short-pitch contacts between 
Arp2 and Arp3. To investigate these possibilities, we first sought more conservative 
mutations to test if destabilization of the splayed Arp2-Arp3 interface is sufficient to 
stimulate the short pitch conformation. We initially considered R441 and N442 in the 
base of the Arp3 C-terminus. These residues contribute to the splayed Arp2-Arp3 
interface, but are also close to the predicted short pitch interface (Fig. 4a, Fig. S2). In 
contrast, the αE/αF loop in subdomain 4 of Arp2 contributes several residues to the Arp2-
Arp3 splayed interface, and none of them are predicted to contribute to the short pitch 
interface (Fig. 5a,b, Fig. S3) 45. Therefore, we constructed budding yeast strains 
expressing Arp2 αE/αF loop mutants as their sole copy of Arp2, then purified and 
characterized the mutant complexes (Fig. 5c). At Arp2 position 207 we changed the wild 
type alanine to bulkier amino acids to disrupt contacts of the αE/αF loop with Arp3. In 
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addition, we mutated Arp2 F203 to Tyr. F203Y is one of two mutated residues found in 
an Arp2 mutant isolated in a genetic screen, arp2-7, that confers increased NPF-
independent activity to the complex13,23,46,47. Because of its position in the Arp2 αE/αF 
loop, we reasoned that the F203Y mutation could also destabilize the Arp2-Arp3 splayed 
interface. To determine if these mutations influence the conformation of the complex, we 
used the short pitch crosslinking assay.  We found that three of the splayed interface 
mutations increased formation of short pitch crosslinks (Fig. 5d,e, Supplementary Table 
2). In one minute reactions, the Arp2-A207W, A207C and F203Y mutants increased 
crosslinking 5, 6 and 12-fold compared to the wild type complex, respectively. These 
results demonstrate that the Arp2-Arp3 splayed interface is critical for holding the 
complex in the inactive conformation. Furthermore, they show that destabilizing the 
splayed interface potently stimulates the short pitch conformation. We note that the 
Arp2(A207I) mutant complex was prone to degradation, but when isolated showed 
similar behavior in the crosslinking assay as wild type complex, indicating not all 
mutations of residue 207 can stimulate the short pitch conformation. 
To determine if the splayed interface mutations increased the NPF-independent 
activity of the complex, we tested the mutants in pyrene actin polymerization assays. The 
Arp2(A207C), Arp2(A207W) and Arp2(F203Y) mutant complexes each showed 
increased NPF-independent nucleation activity compared to wild type Arp2/3 complex, 
consistent with their increased propensity to adopt the short pitch conformation (Fig. 
5f,g). The A207C and F203Y mutations showed the most potent activation, and at 100 
nM increased the maximum polymerization rate 3.6- and 2.6-fold over the wild type 
complex, respectively. The A207W mutant showed a more modest 1.8-fold increase in  
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Figure 5 | Destabilization of the splayed Arp2-Arp3 interface stimulates the short 
pitch conformation and activates Arp2/3 complex.  
(a) Ribbon diagram of Arp2 and Arp3 positioned in the splayed conformation (2P9K). 
Subdomains are numbered, with partially or fully disordered subdomains in Arp2 in 
parentheses. (b) Close up of the Arp2-Arp3 splayed interface, with key residues from 
Arp2 labeled based on S. cerevisiae sequence. (c) Coomassie stained gel of purified wild 
type and splayed interface mutants of ScArp2/3 complex. All budding yeast complexes in 
this panel and in subsequent figures harbor the engineered cysteine residues: 
(Arp2(R198C)/Arp3(L155C)). (d) Anti-Arp3 and anti-Arp2/anti-Arp3 western blots of 1 
min crosslinking reactions with 1 μM wild type or mutant ScArp2/3 complexes in 200 
μM ATP, 1 mM MgCl2, 50 mM KCl, 20 mM Imidazole pH 7.0, and 1 mM EGTA. (e) 
Quantification of reaction described in panel D run in triplicate. Error bars show standard 
error for three reactions. (f) Time course of 3 µM 15% pyrene actin polymerization with 
25 nM wild type or splayed interface mutant Arp2/3 complexes as indicated. No NPF is 
present in these assays. (g) Maximum polymerization rate versus concentration of wild 
type or mutant ScArp2/3 complexes in pyrene actin polymerization assays as described in 
(e). 
 
 
activity compared to the wild type complex, and the A207I mutant was nearly identical to 
wild type. Together, our data demonstrate that destabilization of the splayed interface not 
only potently stimulates formation of the short pitch conformation, but also increases the 
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NPF-independent nucleation activity of the complex. These data support a model in 
which the C-terminus prevents spurious activation of the complex by locking it into the 
splayed conformation.  
 
ATP binding to both actin-related subunits is important for stimulation of the short 
pitch conformational change 
The requirement for the Arp3 C-terminal tail in regulation of Arp2/3 complex in 
vitro and in vivo, together with evidence for structural plasticity of this feature, suggests 
factors that activate Arp2/3 complex could target the tail to decrease the stability of the 
splayed Arp2-Arp3 interface. Structural information addressing the influence of WASP 
family proteins on the complex is limited to low resolution EM reconstructions7,19,20, 
small angle x-ray scattering models18, FRET19,48, crosslinking49-53, photo-activatable label 
transfer-based constraints54, and x-ray crystal structures showing electron densities that 
likely represent partial segments of bound WASP. In these structures, electron density at 
the interface of subdomain 3 and 4 in Arp3 is consistent with three residues of the A 
region of N-WASP 55,56. Further, tubes of electron density at the barbed ends of Arp2 and 
Arp3 in these structures could correspond to the predicted alpha helical segment in C 56. 
The lack of complete high-resolution structures for the bound activators makes it unclear 
how binding of WASP could switch Arp2/3 complex from the splayed to the short pitch 
state.  ATP is also required for activation, and in contrast to other activators, several high-
resolution structures of the complex in apo- versus ATP-bound states are available14-16. 
While these structures show that ATP binding closes the nucleotide binding cleft (NBC) 
of Arp3, Arp2 and Arp3 remain in a splayed conformation, so it is unclear how ATP 
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could contribute to activation. However, in these structures, NBC closure is correlated 
with widening of the barbed end groove and release of the tip of the Arp3 C-terminus33 
(Fig. 6a). These observations led us to propose a model in which ATP helps activate the 
complex by stimulating closure of the Arp3 nucleotide cleft, causing release of the 
autoinhibitory C-terminus from the barbed end groove and subsequent destabilization the 
splayed Arp2-Arp3 interface (Fig. 6a). As a first test of this model, we asked if binding of 
ATP to the complex stimulates population of the short pitch conformation. The 
crosslinking assays in Figures 4 and 5 of this study were run in buffers containing ATP to 
match conditions of polymerization assays, so we ran a set of experiments to directly 
compare short pitch crosslinking with and without ATP. These data demonstrate that 
ATP stimulates the short pitch conformation in the wild type complex. Even after five 
minutes of crosslinking, we did not detect any crosslinking in the absence of ATP, 
whereas 19 ± 2 % of the complex crosslinked in the presence of ATP (Fig. 6b,c).  ATP 
binds to both Arp2 and Arp3, so binding to either Arp could be responsible for 
stimulating the splayed to short pitch conformational change6,30. Therefore, we tested the 
ability of ATP to increase short pitch crosslinking using a previously described mutant 
complex defective in ATP binding to Arp3, Arp3(G358Y)7. Consistent with our model, 
the Arp3 nucleotide binding cleft mutant Arp3(G358Y) reduced the ability of the ATP to 
stimulate short pitch crosslinking, demonstrating that ATP binding to Arp3 is important 
for stimulating the short pitch dimer (Fig. 6d). To probe for a role for ATP binding to 
Arp2, we generated two mutations in the Arp2 NBC, D10A and G302Y. Both of these 
mutations decrease crosslinking of ATP to the Arp2 subunit and potently decrease Arp2/3 
complex activity (Fig. S4) 7. Unexpectedly, both mutations completely blocked ATP-
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induced stimulation of short pitch conformation. Together, these data demonstrate that 
ATP binding to both Arp3 and Arp2 is important for stimulation of the short pitch 
conformation, but that ATP engagement at the Arp2 NBC plays a larger role.   
 To further investigate the link between nucleotide binding and the stability of the 
Arp2-Arp3 splayed interface, we tested how activating mutations in the C-terminus or in 
the Arp2 αE/αF loop influenced the ability of ATP to stimulate the short pitch 
conformation. While the wild type complex showed no short pitch crosslinkling in the 
absence of ATP, two of the mutants, including Arp2(A207C) and Arp2(F203Y), showed 
significant crosslinking in the absence of ATP (Fig. 6d). Importantly, ATP-bound mutant 
complexes showed 8-15 fold more potent crosslinking than ATP-bound wild type 
complex (Fig. 6e, Supplementary Table 3). These data indicate that the intrinsic stability 
of the splayed interface tunes the ability of ATP to shift the conformation toward the 
short pitch state. We note that the relatively weak ATP-induced stimulation of short pitch 
crosslinking in the wild type complex is consistent with the weak NPF-independent 
activity of the wild type S. cerevisiae complex in pyrene actin polymerization assays 
(Fig. 2c)20,57. 
 
Release of the tip of the Arp3 C-terminus from the barbed end groove stimulates 
formation of the short pitch conformation 
Our data show that ATP binding to Arp3 stimulates adoption of the short pitch 
dimer, even though the nucleotide binding site is ~20 Å from the Arp2-Arp3 splayed 
interface. Therefore, we wondered if structural changes initiated at the Arp3 NBC could 
allosterically destabilize the splayed Arp2-Arp3 interface. As mentioned above, crystal  
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Figure 6 | The Arp3 C-terminus is an allosteric molecular switch that locks the 
complex in the inactive (splayed) conformation.  
 (a) Cartoon depicting proposed conformational link between the ATP binding cleft, the 
barbed end groove and the C-terminus of Arp3. Dotted red lines indicate widths of 
nucleotide binding cleft (NBC) and barbed end groove. The tip (T) and base (B) of the 
Arp3 C-terminus are indicated. (b) Time course of crosslinking assays containing 1 µM 
wild type ScArp2/3 complex with or without 100 µM Mg2+-ATP. (c) Quantification of 5 
min short pitch crosslinking for reactions containing 1 µM wild type or ATP-binding 
pocket mutation complexes with either 1 µM EDTA or 200 µM Mg2+-ATP. (d) 
Quantification of 1 min short pitch crosslinking assays of wild-type or splayed interface 
mutations with or without 200 µM Mg2+-ATP. Error bars in panels c and d show 
standard error for three reactions. 
 
structures with ATP bound show the Arp3 cleft in a closed conformation, a state 
correlated with widening of the barbed end groove and disordering of the tip of the Arp3 
C-terminus16,33,58 (Fig. 6a). In contrast, crystal structures of the complex with no 
nucleotide bound to Arp3 tend to show an open NBC, a closed barbed end groove, and 
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the Arp3 C-terminus engaged14,16. These structural comparisons, along with molecular 
dynamics simulations, indicate that the NBC, the barbed end groove, and the Arp3 C-
terminus are allosterically linked33. The structural link between these regions is consistent 
with our measurements of etheno-ATP (ε-ATP) binding to the S. pombe complex, which 
specifically measures nucleotide binding to the Arp3 subunit (see methods). Specifically, 
we found that ε-ATP bound ~2.7 fold more tightly to the Arp3ΔC mutant than the wild 
type SpArp2/3 complex (Fig. S5). Unexpectedly, the binding affinity of ε-ATP for the S. 
cerevisiae complex did not change when the Arp3 C-terminus was deleted (Fig. S5). This 
was surprising given that ATP binding and truncation of the Arp3 C-terminus stimulate 
the same conformational change in ScArp2/3 complex (Fig 4). While we cannot currently 
explain this result, one possibility is that ε-ATP engages the NBC differently than ATP so 
fails to form the same allosteric link to the Arp3 C-terminus. 
The structural link between the nucleotide binding cleft, the barbed end groove, 
and the Arp3 C-terminus suggests that ATP binding could influence the stability of the 
splayed interface by controlling the engagement of the Arp3 C terminus with the barbed 
end groove.  However, in the x-ray crystal structures, nucleotide-induced NBC closure 
generally results in disorder of the tip of the Arp3 C-terminal tail, while the base remains 
fully or partially ordered (Fig. 7a, Fig. S6). The Arp3 C-terminal truncations we describe 
above remove both the tip and base of the tail (Fig. 2b). Removal of base could directly 
destabilize the splayed conformation because it eliminates residues that participate in the 
splayed Arp3-Arp2 interface (Fig. 4a). Therefore, we wondered if disruption of the tip 
alone could allosterically destabilize the splayed interface. To test this, we mutated to 
aspartate the two conserved hydrophobic residues that pin the tip into the barbed end 
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groove (Fig. 7b). Like the complete C-terminal deletion, this mutation, 
Arp3(L445D/F446D), increased NPF-independent activity compared to the wild type 
complex (Fig. 7c,d). In addition, the Arp3(L445D/F446D) mutation stimulated formation 
of the short pitch conformation in the crosslinking assay, despite the fact that neither of 
the mutated residues directly contribute to the splayed interface (Fig. 4a, 7e). Similar to 
the C-terminal deletion mutant, the Arp3(L445D/F446D) mutant required ATP for potent 
stimulation of the short pitch conformation (Fig. 7e). Furthermore, like the Arp3 C-
terminal truncation, the Arp3(L445D/F446D) mutant formed a secondary (non-short 
pitch) Arp3-Arp2 crosslinked band in the BMOE crosslinking assay (Fig. 7f). This 
secondary product forms due to a crosslink between an endogenous cysteine in Arp3, 
C426, and Arp2. C426 is at the barbed end of Arp3 adjacent to the C-terminal tail, and is 
reactive only when the C-terminal tail is deleted, but not in the wild type complex (Fig. 
7b,d, Fig. S7). The C426 non-short pitch crosslink also occurs in the 
Arp3(L445D/F446D) mutant, suggesting that mutation of the tip of the tail increases the 
solvent exposure of Arp3 C426 similarly to the C-terminal truncation, providing 
additional evidence that the Arp3(L445D/F446D) mutation releases the tail from the 
barbed end groove. Together, these data strongly support a model in which release of the 
tip of the Arp3 C-terminus from the barbed end groove allosterically influences the 
conversion from the splayed to short pitch conformation, providing a molecular 
mechanism by which ATP helps relieve autoinhibition of Arp2/3 complex. 
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Figure 7 | Release of the tip of the Arp3 C-terminus from the barbed end groove 
stimulates formation of the short pitch conformation. 
(a) Plot of average main chain B-factor versus residue number for the C-terminal residues 
in Arp3. Data taken from ten different Bos taurus Arp2/3 complex crystal structures in 
different nucleotide-bound states (1K8K, 2P9L, 1U2V, 2P9N, 2P9U, 2P9P, 1TYQ, 2P9I, 
2P9K, 2P9S) (14-16). Nucleotide cleft widths are classified based on Nolen and 
Pollard16.  B-factors were normalized so that each chain had the same average main chain 
B-factor. Residues missing in the electron density are omitted from the plot. Residue 
numbers in parenthesis are for ScArp2/3 complex. See Fig. S6 for more detailed B-factor 
analysis. (b) Surface representation of the barbed end groove with C-terminus of Arp3 
bound (yellow stick representation, black labels) based off of structure 1K8K. Orange 
labels indicate key hydrophobic residues in the Arp3 barbed end groove. C426, a cysteine 
that becomes reactive upon deletion of the Arp3 C-terminal tail, is labeled in magenta. 
Residue labels are based on S. cerevisiae sequence. Black line indicates transition 
between the base and tip of the C-terminal tail. (c) Time courses of polymerization of 3 
μM 15% pyrene actin in the presence of 10 nM wild type, Arp3ΔC, Arp3ΔC(C426A), or 
Arp3(L445D/F446D) ScArp2/3 complexes. The C426A mutation decreased activity 
slightly in the Arp3ΔC complex, but was still hyperactive compared to wild type. (d) 
Maximum polymerization rate versus complex concentrations for reactions described in 
C. (e) Time course of short pitch crosslinking for reactions containing 1 µM wild type, 
Arp3ΔC, or Arp3(L445D,F446D) ScArp2/3 complexes and 200 µM Mg2+-ATP. Error 
bars show standard error for at least three reactions. (f) Two color (anti-Arp2/anti-Arp3) 
western blot of crosslinking reactions containing 1 µM wild type or mutant ScArp2/3 
complexes with or without 200 µM ATP as indicated. Reactions containing wild type and 
Arp3(L445D/F446D) complexes with or without ATP were run for 5 min. Reactions 
containing Arp3ΔC or Arp3ΔC(C426A) complexes were run for 1 min. 
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DISCUSSION 
Our data indicate that Arp2/3 complex must be locked in the splayed conformation to 
prevent its spurious activation. Interactions that stabilize the splayed conformation can be  
described by two major sets of contacts14-16. First, Arp2 and Arp3 are held by a molecular 
clamp formed by ARPC1, ARPC2, ARPC4 and ARPC5 (Fig. S8). The clamp buries 
approximately 1500 Å2 of surface area of Arp2 and 2100 Å2 of Arp3. Second, Arp2 and 
Arp3 interact end-to-end in the splayed conformation within the clamp (Fig. S8). The 
contact area of the splayed Arp2-Arp3 interface is relatively small (~800 Å2), and based 
on computational predictions is not a relevant dimer interface in the absence of the clamp 
(data not shown)59. However, we show that the Arp2-Arp3 splayed interface is critical for 
controlling the conformation of the complex. Furthermore, our data suggest that at least 
one activator, ATP, targets the splayed interface to activate the complex. In addition to 
Arp2/3 complex activators, we note that at least one inhibitor also targets the splayed 
Arp2-Arp3 interface. CK-666, a small molecule Arp2/3 complex inhibitor, binds in a 
pocket at the splayed interface, directly stabilizing the splayed arrangement to inactivate 
the complex22.  Therefore, tuning the strength of the splayed Arp2-Arp3 interface may be 
a general mechanism by which regulators control branching nucleation by Arp2/3 
complex.  
 Here we present a “tail release” model in which the Arp3 C-terminal tail serves as 
a molecular switch that controls the conformation and activity of the complex. In this 
model, when the tip of the tail is released from the barbed end groove, it destabilizes 
interactions between the base of the tail and Arp2, thereby stimulating the short pitch 
conformation (Fig. 6a). Existing biochemical and structural data support the tail release 
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model, but several lines of evidence indicate that activation involves additional structural 
mechanisms. For instance, ATP binding increased short pitch crosslinking in the Arp3ΔC 
mutant, demonstrating that deletion of the Arp3 C-terminal tail is not sufficient to 
completely populate the short pitch state (Fig. 6e). In addition, our data show that ATP-
induced activating structural changes are not exclusively propagated though the Arp3 
subunit. While ATP binding to Arp3 contributed to stimulation of the short pitch 
conformation, mutations that blocked ATP binding to Arp2 completely abolished 
stimulation of the short pitch conformation. This indicates that ATP binding to Arp2 is 
actually more important than Arp3, and that nucleotide binding must also stimulate the 
short pitch conformation through mechanisms not directly involving the Arp3 C-
terminus. We note that several other mutations in Arp2/3 complex are known to increase 
the NPF-independent nucleation activity of the complex. While the structural basis by 
which these mutations relieve autoinhibition is unknown, the location of the amino acid 
changes suggests they may not be directly linked to the tail release mechanism20,25. 
Understanding how multiple structural features in the complex coordinately stimulate 
activation, and how Arp2/3 complex regulators target these features during activation 
remain important open questions. We anticipate that the short pitch crosslinking assay 
will provide an important tool in this regard.  
ATP hydrolysis by Arp2/3 complex stimulates branch disassembly, so the 
requirement for ATP in activation creates a built in timing mechanism to control turnover 
of branched actin networks28-30. Mutational analysis shows that ATP binding to both 
Arp2 and Arp3 is important for branching nucleation7,21, but how nucleotide binding to 
either Arp subunit could influence the activity of the complex was unknown. Here we 
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show that ATP stimulates formation of the short pitch conformation, explaining how it 
contributes to activation. By mutating the nucleotide binding cleft of Arp3, we showed 
that ATP binding to Arp3 is important for stimulation of the short pitch conformation, 
consistent with the tail release model. Previously published FRET experiments are 
consistent with our data, since mutations in the Arp3 NBC blocked an ATP-induced 
increase in FRET21. However, these data also showed that NBC mutations in Arp2 did 
not block the conformational change measured by FRET 21, whereas the same mutations 
completely blocked short pitch crosslinking in our assays here, making it unclear if the 
FRET assay measures the short pitch conformational change. That ATP binding to Arp2 
stimulates the short pitch conformation is also supported by a previously described NBC 
mutation in Arp2, Y309A. Arp2-Y309A increases the activity of the complex both in the 
presence and absence of NPF7. In EM reconstructions of negatively stained particles, the 
Y309A complex favors a conformation more closely resembling the wild type NPF-
bound than free complex7. This suggests it may stimulate the short pitch conformation, 
and that like Arp3, the nucleotide cleft of Arp2 is allosterically linked to overall positions 
of Arp3 and Arp2 in the complex. Dissection of the structural basis for this allosteric link 
will be important for understanding how Arp2/3 complex is activated. In addition, we 
note that at cellular concentrations, ATP will bind rapidly to the nucleotide-free Arp 
subunits, so the apo-complex is likely more transient that the ADP-bound states. 
Therefore, determining precisely why ADP cannot activate Arp2/3 complex will also be 
important for understanding the nucleotide-controlled timing mechanism for branch 
dissociation.   
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Mutations that selectively uncouple the activity of Arp2/3 complex from each of 
its activating inputs (ATP, actin monomers, actin filaments, and NPFs) will be critical to 
understand how Arp2/3 complex integrates activating signals to control branching 
nucleation in vivo4-10. While substantial work remains to identify new mutants and 
characterize existing ones, important trends have already emerged. First, despite potent in 
vitro NPF-independent activation by some mutations, the phenotype of existing 
activating mutations is relatively mild. For instance, deletion of the Arp3 β4/β5 insert 
increased activation of S. pombe Arp2/3 complex by WASP (Wsp1), but had no influence 
on endocytic actin patches24. Similarly, the budding yeast Arp2(Y309A) mutant showed 
no obvious defects in endocytic actin patch localization or organization7. The arp2-7 
budding yeast strain, which harbors the Arp2(F203Y) mutation we characterize here (plus 
one additional mutation in Arp2), showed defects in patch dynamics13,23,46,47, but like the 
arp3ΔC strain, the patches remained cortical and resembled wild type actin patches. The 
failure of existing activating mutations to cause accumulation of ectopic actin structures 
suggests additional mechanisms regulate the activity of the mutant complexes in vivo. 
One possibility is that these mutations fail to uncouple the activity of the complex from 
the requirement to bind preformed filaments. Consistent with this hypothesis, several 
experiments suggest the in vivo activity of wild type Arp2/3 complex is limited by the 
availability of suitable preformed substrate filaments9,43,60. Negative regulators of the 
complex or its activators (e.g., Crn1, Syp1, Bbc1, Sla1, Lsb1) may also dampen the in 
vivo influence of the mutations, explaining the mild phenotypes13,51,61,62. A second 
emerging trend is that while relatively mild, the phenotypes of each of the activating 
mutations are distinct. These differences cannot be explained by the relative in vitro 
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potency of the mutations. For instance, the S. pombe Arp3ΔC mutation shows modest 
activity in vitro but has the most pronounced influence on actin dynamics in vivo. We 
speculate that the precise molecular mechanism by which these mutations uncouple 
activation from activating inputs influences their in vivo effect on actin dynamics. We 
note that the Arp3ΔC mutant is particularly intriguing in that its influence on the 
dynamics of the actin patches (increased Fim1 lifetime and defective internalization) is 
similar to what has been observed for mutations that compromise the activity of the 
complex rather than activate it 7,13.  We anticipate that further dissection of this and other 
key Arp2/3 complex mutants will provide important insight into the in vivo function of 
the complex. 
 
MATERIALS AND METHODS 
 
Construction of fission yeast strains 
A fission yeast strain harboring the arp3ΔC(416-427) mutation was made by 
transforming the TP150 strain with a cassette harboring a premature stop codon and the 
KanMX6 marker as described 34. FIM1 was tagged with GFP by homologous 
recombination strategy using a cassette generated from pFA6a-GFP-NatMX6 63. Both 
integrations were confirmed by amplifying and sequencing the entire regions. See 
Supplementary Table 4 for all fission yeast strains used in this study.  
 
Construction of budding yeast strains 
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Splayed interface mutations in Arp2 were constructed by Quick Change PCR using as a 
template a previously constructed vector in which arp2(R198C) was subcloned into 
pRS317 with native promotor and terminator sequences22. Arp3(L445D/F446D), 
Arp3ΔC440-449 and Arp3ΔC440-449(C426A) expression plasmids were created by the same 
method, using a previously described template in which arp3(L155C) is flanked by native 
promoter and terminator sequences was cloned into pRS315. These plasmids were 
introduced into haploid strains with the corresponding Arp subunit knocked out and 
rescued on a URA plasmid. Haploid strains expressing Arp subunits off of the pRS 
plasmids were then mated, sporulated and selected through random spore analysis as 
previously described to generate the final yeast expression strains22. See Supplementary 
Table 5 and 6 for all budding yeast plasmids and strains used in this study. 
 
Protein purification and labeling  
Pyrene labeled rabbit skeletal muscle actin was purified and labeled as previously 
described22,24. For expression of S. pombe Arp2/3 complex, S. pombe cells were grown in 
200 mL of YES medium at 30 °C. After ~24 hours, 10 mL of this culture was used to 
inoculate 1 L cultures of YES, which were grown at 30 °C for 12-16 hours. An additional 
35 g of YES was added to each 1 L culture, and cells were grown to an optical density at 
600 nm of ~6.0 before harvesting. To produce S. cerevisiae cell pellets for protein 
purification, a starter culture grown in synthetic media lacking leu, lys, his, and trp was 
added to 1 L YPD medium and allowed to grow to OD600 ~7-8. An additional 50g/L YPD 
powder was added and cells were harvested at OD600 ~15-16. Before harvesting, 2 mM 
EDTA and 0.5mM PMSF was added to prevent proteolysis. Cells were pelleted in a F8B 
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rotor at 5K rpm for 5 minutes. Cells were resuspended in lysis buffer (20 mM Tris pH 
8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT), and stored at -80 degrees Celsius. S. 
pombe Arp2/3 complex was purified as previously described using an ammonium sulfate 
cut, a GST-N-WASP-VCA affinity column, a MonoQ anion ion exchange column (GE 
Healthcare), and a Superdex 200 gel filtration (GE Healthcare)24. S. cerevisiae Arp2/3 
complexes were purified using an ammonium sulfate cut, a GST-N-WASP-VCA affinity 
column, and a gel filtration step, as previously described22. Unlike the other complexes 
reported here, the Arp3ΔC mutant complexes could not be eluted from a GST-N-WASP-
VCA affinity column using high salt. These complexes were instead eluted with 50 mM 
reduced glutathione solution. The pooled fractions were then purified by monoQ and 
glutathione sepharose columns to remove any contaminating GST-N-WASP-VCA. Like 
the wild type complexes, the Arp3ΔC complexes were gel filtered as a final purification 
step before flash freezing in liquid nitrogen. Anti-GST (Genescript A00865) western 
blots were used to demonstrate that there was no detectable GST-N-WASP-VCA in the 
complexes prepared with the modified purification method (Fig. S9).  
 
Pyrene actin polymerization assays and kinetic data analysis  
Pyrene actin polymerization assays were carried out as previously described22. 
Fluorescence changes were monitored by exciting the sample at 365 nm and measuring 
the emission at 407 nm using a Tecan Safire 2 plate reader. The maximum rate of 
polymer formation was calculated as previously described22. 
 
Microscopy 
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TIRF microscopy was carried out as previously described using a Nikon TE2000-U 
microscope outfitted with a 100 x TIRF objective lens, a 488 nm argon laser and a 561 
nm diode laser24. Confocal microscopy of S. pombe cells was carried out at 30 °C on the 
same microscope, using a Yokagawa CSU10 spinning-disc head. Cells were maintained 
in the exponential phase for 2 days before immobilization on a gelatin pad as described64.  
Images were collected using Micomanager software and actin patches were tracked 
manually in Image J65,66. For patch internalization measurements, patches were tracked 
from x separate cells in x different movies, using custom Matlab particle tracking scripts 
67. Patches that moved 2 pixels (~0.2 μm) from their origin were classified as 
internalized, even if the patch movement was not perpendicular to the cell cortex. To 
quantify the intensity of patches over time, a circle with a diameter of seven pixels was 
drawn in ImageJ over isolated patches and the intensity was measured for each frame. 
The background was subtracted by measuring the intensity of a circle of the same size in 
the cytoplasm of the cells. Due to the frequent patch internalization failures in the 
Arp3ΔC strain, patches were aligned to the maximal intensity of Fim1-GFP, which 
typically reflects the time at which patch movement starts to occur 41,68.  FM4-64 uptake 
assays were carried out as previously described69. 
 
ε-ATP binding assays 
ε-ATP binding was measured by titration of a solution of 0.5 μM wild type or mutant 
fission yeast Arp2/3 complex in 10 mM Hepes pH 7.0, 50 mM KCl, 1 mM EGTA, 1 mM 
MgCl2, 1 mM DTT, 1.4 % acrylamide with ε-ATP and measuring the fluorescence at 420 
nm (excitation = 340 nm). The background fluorescence of unbound ε-ATP was 
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subtracted by assuming a linear relationship between the signal and ε-ATP at saturating 
concentrations.  Data were fit as previously described24. We note that while both actin-
related subunits in the complex bind nucleotide, previous experiments showed that 
mutations in the Arp2 binding pocket that potently decreased crosslinking of ATP to 
Arp2 had no influence on the nucleotide affinity measured by this assay, indicating ε-
ATP measures binding specifically to the Arp3 subunit 7. 
 
Short pitch crosslinking assays 
All crosslinking assays were performed with budding yeast Arp2/3 complex containing 
the arp2(R198C) and arp3(L155C) mutations. Reaction mixes containing Arp2/3 
complex with or without additional components (e.g, ATP or NPF) in KMEI were mixed 
with 4 μL of 125 μM BMOE for indicated times at 21 °C before adding SDS-PAGE 
loading buffer (1xSDS-PAGE buffer: 0.3 % SDS, 33 mM DTT, bromophenol blue) to 
stop the reaction. Reactions mixes were analyzed by SDS-PAGE and western blotting 
with goat anti-Arp3 (Santa Cruz, sc-11973, 1:1000 dilution), goat anti-Arp2 (Santa Cruz, 
sc-11969, 1:1000 dilution) or mouse anti-Arp3 (Santa Cruz, sc-376625, 1:1000 dilution) 
antibodies. Blots were imaged using a LICOR Odyssey Fc system.  
 
Structural modeling 
Models used for surface area and pKa calculations were constructed by first creating 
homology models of ScArp2 and ScArp3 with SWISS-Model 
(http://swissmodel.expasy.org) using 4JD2 as a template. Arp2 was then moved into the 
short pitch conformation using the Oda, et. al. filament model 70. Specifically, Arp3 was 
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superposed onto an actin subunit and Arp2 was then overlaid onto the subunit in the short 
pitch position relative to Arp3. The geometry of the structure was minimized using 
Phenix before running the calculations71 
 
 
BRIDGE TO CHAPTER III 
 In this chapter, we investigated the structural features that hold Arp2/3 complex in 
its inactive conformation. We found that the splayed interface between Arp3 and 
subdomain 4 of Arp2 and the Arp3 C-terminus are key regions for holding the complex 
in its inactive state and disruption of these regions has dramatic effects both in vitro and 
in vivo. This work demonstrates that binding of ATP to both Arp subunits forms an 
allosteric link that is required for formation of the short pitch conformation and that one 
mechanism for this observed effect is due to displacement of the Arp3 C-terminus. In 
chapter III, we will investigate the role of a different activator of Arp2/3 complex, 
WASP, and biochemically dissect the requirements for stimulation of conformational 
changes by this NPF. 
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CHAPTER III 
 
THE ROLE AND STRUCTURAL MECHANISM OF WASP-TRIGGERED 
CONFORMATIONAL CHANGES IN BRANCHED ACTIN FILAMENT 
NUCLEATION BY ARP2/3 COMPLEX 
 
AUTHOR CONTRIBUTIONS 
B.J.N. and M.R.-S. designed the experiments and interpreted the data. B.J.N. and M.R.-S. 
wrote the manuscript. B.J.N., M.R.-S., Q.L., and S.-L.L., generated reagents and carried 
out experiments.  
 
INTRODUCTION 
Proper regulation of the actin cytoskeleton is critical for cells to orchestrate 
processes like division, differentiation, motility and endocytosis. Assembly of new actin 
filaments is limited by a slow nucleation step, and cells rely on three classes of actin 
filament nucleators - tandem WH2 domain proteins, formins, and Arp2/3 complex - to 
control precisely when and where actin filament networks assemble (1, 2). Arp2/3 
complex is unique among actin filament nucleators in that it typically nucleates branched 
(as opposed to linear) actin filaments (3-5).  Branched actin filaments are important for 
assembling dendritic networks required for lamellipodial protrusion and endocytosis (6, 
7).  
Arp2/3 complex is tightly regulated, and multiple factors, including preformed 
actin filaments, actin monomers, ATP, and a class of proteins called nucleation 
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promoting factors (NPFs) are typically required for activation (5-7). In some species, 
phosphorylation of Arp2/3 complex is also required for activation (8). WASP (Wiskott-
Aldrich Syndrome Protein) family proteins are the best understood NPFs, and share a 
conserved polypeptide sequence called VCA (Verprolin homology, Central, Acidic), 
which constitutes the minimal region sufficient for Arp2/3 complex activation.  WASP 
proteins interact with actin monomers through their V and C regions, and bind Arp2/3 
complex through C and A regions (9, 10). How WASP proteins activate Arp2/3 complex 
is unknown, but available data suggest they play multiple roles in the branching 
nucleation reaction. For instance, several lines of evidence indicate the CA segment of 
WASP proteins stimulates a conformational change in the complex important for 
activation (11-15). In addition, WASP-VCA recruits actin monomers to the complex 
through its V region. Kinetic simulations of the weak NPF-independent activity of 
Arp2/3 complex suggested actin monomers must bind the complex to form a nucleus, 
leading to the idea that WASP-recruited monomers could “jump start” nucleation (16, 
17). The observation that the V region is required for WASP-mediated activation of the 
complex supported this idea, and indicated that direct monomer tethering might not only 
accelerate nucleation, but might be a general requirement for assembly of the nucleus (9, 
10, 12). In addition to its activating influence, WASP-VCA can also have an inhibitory 
influence on the kinetics of branching nucleation. Specifically, recent single molecule 
TIRF experiments showed that VCA must be released from nascent branch junctions 
before nucleation, and that slow WASP-VCA release limits nucleation rates (18, 19). 
Efforts to understand the relative contributions of each of these roles of WASP on 
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activation have been hampered by a lack of methods that can disentangle these functions 
or directly probe the connection between conformation and activity.  
Two of the seven protein subunits in Arp2/3 complex, Arp2 and Arp3, are 
homologous to actin. High-resolution crystal structures of inactive Arp2/3 complex show 
Arp2 and Arp3 interacting end-to-end in a “splayed” conformation (20-23). Upon 
activation, Arp2 is hypothesized to undergo a rigid body movement that moves it ~20 Å 
into position next to Arp3, forming an Arp2-Arp3 “short pitch” dimer that structurally 
mimics two consecutive actin subunits within a filament (20, 24). Low-resolution EM 
structures of Arp2/3 complex bound to the WASP proteins N-WASP or WAVE1 support 
this hypothesis, since they show Arp2 and Arp3 in a filament-like arrangement (15). In 
addition, recent experiments demonstrated that N-WASP stimulates site-specific 
crosslinking of engineered cysteines on Arp2 and Arp3 that react only when the complex 
adopts the short pitch conformation (11). These studies suggest a general function of 
WASP proteins may be to stimulate the short pitch conformation, providing an 
explanation for how they could activate the complex. However, whether this function is 
conserved among WASP proteins, and if adoption of the short pitch conformation is 
sufficient for activation is unknown. Importantly, because WASP must recruit actin 
monomers to the complex for potent activation (9, 12), it is possible that the short pitch 
Arp2-Arp3 dimer provides only the initial core of a nucleus, to which one or more 
WASP-tethered actin monomers must be added for nucleation (7). Therefore, whether 
stimulation of the short pitch conformation without direct monomer tethering could 
activate the complex is unknown.   
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Understanding WASP-mediated activation requires knowledge of both the role of 
the short pitch conformation and the mechanism by which WASP proteins could 
stimulate this conformational change. Despite numerous studies, how the WASP CA 
region binds Arp2/3 complex is still unclear. Biophysical and biochemical experiments, 
including analytical ultracentrifugation, isothermal titration calorimetry, and crosslinking 
indicate that Arp2/3 complex binds two WASP-CA molecules (25-27). Crosslinking and 
label transfer experiments suggest one CA binding site is on Arp3 and the second spans 
Arp2 and ARPC1 subunits (10, 25, 28-30). NMR line broadening experiments and 
mutational analyses suggest that the C region forms an amphipathic helix when it binds to 
the complex (31). Together with homology modeling and recent low resolution crystal 
structures, these data suggest that the C helix binds the barbed end groove of each Arp 
like the V region helix binds the barbed end groove of actin (25-27, 32) (Fig. 1A). Less is 
known about interactions with A, but a short segment of electron density between 
subdomains 3 and 4 in Arp3 in a co-crystal structure was interpreted as the conserved 
tryptophan from the A region of one bound WASP (27). The second A region is thought 
to bind the ARPC1 subunit, since this subunit in isolation can bind to VCA in a mode 
dependent on the conserved tryptophan (33). These data, together with distance 
measurements reported in a recent FRET study (26), have led to an approximate model 
for CA binding at each site (Fig 1A). This model is consistent with the majority but not 
all of the published data (15), and provides an important starting point for understanding 
the molecular basis for WASP-mediated conformational changes. Surprisingly, few 
studies have used mutational dissection of the complex to investigate WASP binding, and 
little high-resolution structural informational is available (27, 34), so the model remains 
 55 
 
 
tentative. Furthermore, the lack of biochemical dissection leaves open the important 
question of how engagement of WASP could stimulate the conformational rearrangement 
of the complex thought to be required for activation.  
Here we use a newly developed engineered cysteine crosslinking assay to 
investigate the role of the short pitch conformation in Arp2/3 complex activation (11). 
Crosslinking the engineered cysteines to hold Arp3 and Arp2 in or near the short pitch 
conformation bypasses the need for WASP in activation. Remarkably, the complex 
shows NPF-independent hyperactivity when crosslinked in this conformation. This result 
indicates that the switch to the short pitch conformation is a critical activation step, and 
that direct actin monomer recruitment by WASP-VCA is not required for potent activity. 
Our crosslinking experiments indicate that stimulation of the short pitch conformation is 
a conserved feature of WASP proteins, and that the CA region is sufficient for this 
function. However, our data also suggest that the activating effect of the WASP-mediated 
conformational change may be masked by slow release of WASP from nascent branch 
junctions. Using structure-based mutational analysis and WASP-Arp fusion chimeras, we 
determined one mechanism by which WASP proteins can stimulate movement of the 
Arp2 and Arp3 subunits into the short pitch conformation. We show that WASP 
competes for binding to the barbed end groove of Arp3 with the Arp3 C-terminal tail, a 
structural element that forms an allosteric switch responsible for autoinhibition of the 
complex. These data support a model in which WASP binds the Arp3 barbed end groove, 
displacing the Arp3 C-terminal tail to relieve autoinhibiton and stimulate the short pitch 
conformation. 
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Results 
Stimulation of the short pitch conformation is a conserved feature of WASP family 
NPFs 
Several studies show that WASP family proteins cause conformational changes in 
Arp2/3 complex, and that these changes are likely important for activation. For example, 
binding of WASP-VCA to an Arp2/3 complex tagged with fluorescent proteins on 
ARPC1 and ARPC3 caused a conformational change detected by increased FRET (12). 
Mutations that blocked the conformational change decreased the activity of the complex 
(12). Similarly, EM reconstructions of negatively stained Arp2/3 complexes showed the 
WASP protein Las17 caused structural rearrangements interpreted as repositioning of 
Arp2 (13, 14). Electron densities from higher resolution EM reconstructions (~2.0 nm) of 
N-WASP and WAVE1-bound complexes showed a short pitch arrangement of Arp2 and 
Arp3 that could template nucleation (15). We reasoned that if stimulation of the short 
pitch conformation is important for activation, it should be a conserved function of 
WASP family proteins. To test this, we took advantage of a recently developed 
crosslinking assay in which engineered cysteines on budding yeast Arp2 and Arp3 
crosslink only when the complex is in or very near the short pitch conformation (11) (Fig. 
1B). Treatment of the dual cysteine engineered Arp2/3 complex with the 8 Å crosslinker 
BMOE produces a high molecular weight band cross reactive with both Arp2 and Arp3 
antibodies (Fig. 2A). This band does not form in either of the single cysteine complexes 
(Fig. 2A). Furthermore, the engineered cysteines do not significantly influence the 
activity of the complex, demonstrating that the crosslinking assay can be used to probe 
for the conformational switch (11). We tested the influence of canonical WASP family  
 57 
 
 
 
Figure 1: Hypothesized CA binding mode and schematic of short pitch crosslinking 
assay.   
A. Hypothetical model showing proposed binding sites for WASP family CA region on 
Arp2/3 complex. Arp2/3 complex surface representation is based on the structure of 
GMFγ-bound Arp2/3 complex (4J2D) (23). B. Ribbon diagrams of Arp2 and Arp3 in the 
splayed and short pitch conformations showing design of engineered crosslinking assay.  
Structure 4JD2 was used to make both panels. In the right panel, the Oda, et. al. actin 
filament structure was used to move Arp2 into the short pitch conformation (67). 
Engineered cysteines (Arp3(L155C), Arp2(R198C)) are highlighted in cyan. Black arrow 
shows the direction of the ~20 Å movement required to position Arp2 into the short pitch 
conformation. The structure of the chemical crosslinker (BMOE) used in the short pitch 
crosslinking assay is indicated. The distance between engineered cysteines is 32.5 Å in 
the splayed conformation, and ranges from ~8-13 Å in different models of the short pitch 
conformation. (Also see SI Appendix, Fig. S1). 
 
 
members from mammals and budding yeast on crosslinking of the dual cysteine 
engineered complex. Each NPF was added at multiple concentrations to reach saturation 
and remove the influence of binding site occupancy on the conformation. VCA segments 
from N-WASP, WAVE1, WASP, and Las17 each potently increased crosslinking (Fig. 
2B,C, SI Appendix, Table S1). In one minute crosslinking reactions, near saturating 
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concentrations of each WASP family protein produced ~23-32% cross linked complex, a 
7-10 fold increase over reactions without NPF. Multiple lines of evidence indicate the 
influence of these NPFs is not due to a change in the chemical reactivity of individual 
engineered cysteine residues, but instead due to increased population of the short pitch 
conformation. First, while WASP binding could influence the pKa of the cysteine thiol 
groups and formation of the thiolate, the high concentration of negative charges of the 
WASP A regions would be more likely to decrease than increase cysteine reactivity (35). 
Second, a chemically conservative point mutation in N-WASP potently reduces 
stimulation of the short pitch crosslinking even at saturation (see below). This residue 
was previously determined by FRET to influence WASP-mediated conformational 
changes in the complex (12).  
To better understand the structure of the BMOE crosslinked complex, we used 
morphing software to move Arp2 from its position in an inactive (splayed) crystal 
structure (4JD2) to its short pitch position in the low-resolution EM structure of Arp2/3 
complex at a branch junction (24). At each point in the trajectory we calculated the 
solvent accessible surface crosslinking distance between the engineered cysteines (36). 
Given the crosslinker link of ~8 angstroms for BMOE, this analysis suggests that the 
crosslinked complex is either in or very near the short pitch conformation (SI Appendix, 
Fig. S1). Therefore, for simplicity, we will refer to the covalently trapped conformation 
as the short pitch conformation in the sections that follow. We discuss the possible 
limitations of this interpretation in the discussion section. Given these considerations, we 
conclude from the data above that diverse WASP proteins stimulate movement of Arp2 
and Arp3 into the short pitch “filament-like” arrangement. Importantly, N-WASP-CA 
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alone stimulated this conformation as potently as N-WASP-VCA, consistent with binding 
assays showing that CA but not V interacts with Arp2/3 complex (Fig. 2B,C) (10).  
 
CA binding to both Arp2 and Arp3 is important for stimulation of the short pitch 
conformation 
Our data indicate that diverse WASP proteins stimulate the short pitch 
conformation, suggesting this structural state is important for activation. To better 
understand the role of the short pitch conformation and how it is promoted, we attempted 
to create a “locked” short pitch complex by fusing WASP-CA segments onto the C-
terminus of either Arp2 or Arp3 in budding yeast Arp2/3 complex. We designed these 
fusions based on the binding mode previously proposed for WASP CA on each Arp (Fig. 
1A)(25-27). Fusions were made in the context of the engineered cysteine mutations to 
allow us to test for formation of the short pitch conformation. We reasoned that this 
design could potentially create a constitutively activated complex, and provides a method 
to dissect the importance of CA engagement at each binding site. Furthermore, the fused 
WASP segments lack V regions, conferring two additional advantages. First, the fused 
CA cannot recruit monomers to the complex, potentially allowing us to isolate the role of 
CA-stimulated conformational changes in activation. Second, the V region is proposed to 
block elongation of nascent branch junctions, necessitating WASP release (32, 37). By 
not including the V region we aimed to eliminate the requirement for WASP release in 
the nucleation reaction. We show below that the fused CA segments properly engage the 
complex. Unexpectedly, we found that while CA fusion to either Arp2 or Arp3 
stimulated the short pitch conformation, the effect was modest (Fig. 3A-C, SI Appendix,  
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Figure 2: Stimulation of the short pitch conformation is a conserved feature of 
WASP family NPFs.   
A. Single or two color western blots of short pitch crosslinking reactions containing 1 μM 
wild type (wt), dual cysteine (Cys-Arp), or single cysteine (Arp2-Cys or Arp3-Cys) S. 
cerevisiae (Sc) Arp2/3 complexes and 25 μM BMOE reacted for 0 or 5 min. B. Single 
color western blot of one minute crosslinking reactions containing 1 μM dual cysteine 
(Cys-Arp), 25 μM BMOE, and 30 μM WASP family protein, as indicated. C. 
Quantification of reactions similar to those described in B, except multiple concentrations 
were tested. Parenthesis indicate concentrations of WASP-CA used (in μM). Error bars 
show standard error from three reactions.  
 
Table S2). Both CA-fusions failed to crosslink to the levels observed for wild type 
complex saturated with free N-WASP-CA. These observations suggest that binding of 
WASP-CA to both Arp2 and Arp3 is required to maximally stimulate the conformational 
switch. To challenge this hypothesis, we added free CA to each of the fusion complexes. 
Free WASP-CA added to the Arp3-CA fusion complex increased crosslinking to a level 
nearly identical to that observed with wild type complex with saturating CA (23 ± 2 % 
versus 26 ± 2%), demonstrating that binding to both sites is required for potent short 
pitch stimulation (Fig. 3A-C). This result also shows that CA fused to Arp3 is nearly 
fully functional in its ability to stimulate the short pitch conformation, since addition of 
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free CA (to saturate the unoccupied Arp2 site) increases crosslinking efficiency to nearly 
the same level as CA-saturated wild type complex. Addition of CA to the Arp2-CA 
fusion complex yielded less short pitch crosslinking than CA-saturated wild type 
complex (19 ± 2 % versus 26 ± 2%), suggesting that the Arp2-CA fusion is only partially 
functional in its stimulating the short pitch conformation, potentially due to a minor 
defect in the way the fused CA engages Arp2.  We also attempted to create a dual CA-
fusion complex, but sporulation of diploid yeast strains containing both Arp3-CA and 
Arp2-CA chimeras never yielded a haploid strain containing both chimeras in the absence 
of the wild type Arps, indicating that the dual CA fusion complex does not support 
viability.  
 
CA release from Arp3 is likely important for nucleation 
 We next asked how fusion of CA to the complex influenced its nucleation 
activity. Specifically, we wondered if the modest increased population of the short pitch 
conformation in each CA fusion would result in increased nucleation activity of these 
complexes. As expected, the Arp2-CA fusion complex showed increased NPF-
independent activity in pyrene actin polymerization assays compared to the wild type 
complex (Fig. 3D). In contrast, CA fused to Arp3 potently inhibited the complex, despite 
the fact that it stimulated the short pitch conformation (Fig. 3D). Previous experiments 
showed that WASP must be released from the nascent branch junction before nucleation 
(19), so we hypothesized that the decreased activity of the Arp3-CA fusion complex is 
due to slow (or no) CA release. To test this, we measured the influence of free CA on the 
activity of wild type and Arp2-CA fusion complexes. Addition of free CA blocked the 
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activity of both of these complexes in pyrene actin polymerization assays (Fig. 3E). 
Therefore, these data are consistent with a model in which slow CA release stalls 
branching nucleation. This result was unanticipated, because previous structural 
modeling predicted V (and not CA) sterically blocks actin monomers from associating 
with nascent branches to initiate elongation, necessitating WASP release (32, 37). Our 
data suggest that CA alone can block elongation. However, it is important to note that we 
cannot currently eliminate the possibility that fusion of CA to Arp3 may inhibit the 
complex for reasons unrelated to CA release. For instance, one study reported that CA 
binding to one of the two sites could inhibit the complex from binding to preformed 
filaments, so fused CA could block activation by inhibiting filament binding (27).   
 
Locking Arp2/3 complex into the short pitch conformation causes potent NPF-
independent activity 
We created the CA fusion complexes to isolate the influence of the short pitch 
conformation on the branching nucleation reaction. However, the CA fusions had 
complicated effects on the reaction, both stimulating the short pitch conformation and 
presumably decreasing nucleation by preventing CA release. Therefore, we sought a new 
strategy to probe the role of the short pitch conformation. Our crosslinking experiments 
showed that even without WASP, a small fraction of the complex adopts the short pitch 
conformation (Fig. 2A,C), consistent with the weak NPF-independent activity of the 
budding yeast complex (13, 38). Therefore, we reasoned that crosslinking could be used 
to trap a fraction of the complex in the short pitch conformation to directly test its 
influence on nucleation activity. We crosslinked the dual cysteine complex with BMOE,  
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Figure 3: CA binding to both Arp2 and Arp3 is important for stimulating the short 
pitch conformation change.  
A. Anti-Arp3 western blots of short pitch crosslinking assays containing 1 μM wild type 
or CA-fusion ScArp2/3 complexes (with dual cysteine mutations) and 25 μM BMOE 
reacted for 1 min in the presence or absence of 20 μM N-WASP-CA. B. Quantification of 
three reactions run under conditions described in A. Error bars show standard error of 
three reactions. C. Cartoon summarizing the short pitch crosslinking results for wild type 
and CA fusion complexes with or without N-WASP-CA. The average percentage of short 
pitch crosslinked product formed under each condition is indicated. D. Maximum 
polymerization rate vs. concentration of wild type or Arp-CA fusion complexes in 3 µM 
15% pyrene actin polymerization assays. E. Time courses of 3 µM 15% pyrene actin 
polymerization assays containing 100 nM wild type or Arp2-CA fusion complex with and 
without 20 µM N-WASP-CA. 
 
quenched the reaction at various time points with DTT, and tested the product in pyrene 
actin polymerization assays without NPFs (Fig. 4). Remarkably, crosslinking potently 
activated the NPF-independent activity of the complex, demonstrating that adoption of 
the short pitch conformation is a critical activation step (Fig. 4). These results were 
unexpected because, as noted above, direct recruitment of actin monomers by WASP is 
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required for WASP-mediated activation of Arp2/3 complex (9). Our data demonstrate 
that even in the absence of VCA-mediated monomer tethering, the complex is activated 
once locked in the short pitch conformation.  
 
The complex locked into the short pitch conformation is hyperactivated 
Our data suggest the dominant activating influence of WASP on the kinetics of 
branching nucleation stems from its influence on the conformation of Arp2/3 complex. 
However, WASP-mediated activation of Arp2/3 complex involves additional steps that 
could also influence branching rates, including direct monomer recruitment and WASP 
release from the branch junctions. To better understand the relative contribution of each 
of these steps to the reaction kinetics, we directly compared the NPF-independent activity 
of the crosslinked complex to WASP-activated uncrosslinked complex. To accomplish 
this, we first separated the crosslinked complex from uncrosslinked complex using an 
affinity column charged with GST-tagged Dip1, a recently described Arp2/3 complex 
activator which binds preferentially to the crosslinked complex (5)(SI Appendix, Fig. 
S2). This protocol yielded 98% pure crosslinked complex (Fig. 5A). In pyrene actin 
polymerization assays, 10 nM purified crosslinked complex produced a maximum 
polymerization rate of 40.6 ± 2.2 nM/s with a time to half maximal polymerization of 
33.3 ± 5.8 s (Fig. 5B-D). By comparison, activation of the uncrosslinked complex by the 
optimal concentration of N-WASP-VCA produced a slower maximum polymerization 
rate (28.5 ± 1.0 nM/s) and an increased t1/2 (93.3 ± 5.8 s) (Fig. 5B-D). These observations 
lead to the surprising conclusion that the crosslinked complex is more active than N-
WASP-activated uncrosslinked complex. In some contexts, dimerizing WASP increases  
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Figure 4: Locking Arp2/3 complex into the short pitch conformation bypasses the 
requirement for NPFs in activation.  
A. Western blot of SDS-PAGE gel of crosslinking reactions containing 1 μM dual 
cysteine ScArp2/3 complex (Cys-Arp) and 25 μM BMOE. Reactions were quenched with 
1 mM DTT at the times indicated. B. Quantification of data in A. Error bars show 
standard errors from three separate reactions. C. Time course of pyrene actin 
polymerization for assays containing 3 μM 15% pyrene-labeled actin and 10 nM dual 
cysteine complex crosslinked for the times indicated. AU, arbitrary units. D. Fold 
activation of dual cysteine complex calculated by dividing the maximum polymerization 
rate at a given crosslinking time by the maximum polymerization rate of the 
uncrosslinked complex. Data taken from panel C. E. Plot of number of barbed ends 
created versus time for reactions in C. 
 
NPF activity (25, 37, 39), so we also compared optimal activation of the uncrosslinked 
complex by GST-Las17-VCA and leucine-zipper dimerized N-WASP-VCA to the 
activity of the crosslinked complex. Neither of these NPFs activated the uncrosslinked 
complex as potently as crosslinking (Fig. 5B,C). The maximum polymerization rate in 
reactions containing Arp2/3 complex with either GST-Las17-VCA or LZ-N-WASP-VCA 
was ~4 fold less than reactions with the same concentration of short pitch crosslinked 
complex. These data demonstrate that the crosslinked complex is hyperactivated 
compared to WASP-activated Arp2/3 complex. One explanation for this phenomenon is  
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the slow WASP release step is bypassed in the WASP-independent activity of the short 
pitch crosslinked Arp2/3 complex.  To challenge this model, we tested the influence of 
free WASP-CA on the activity of the crosslinked complex. As predicted, CA inhibited 
nucleation, supporting a model in which locking the complex into the short pitch 
conformation hyper-activates it by allowing it to bypass the slow WASP release step (Fig 
5E,F). We note that other attributes of the crosslinked complex may also contribute to its 
hyperactivity. For instance, WASP-bound Arp2/3 complex may not fully populate the 
short pitch state, leading to decreased nucleation rates compared to the crosslinked 
complex. In addition, if the crosslinked complex requires preformed filaments for 
nucleation, CA could inhibit by decreasing actin filament binding (27). However, CA did 
not block the crosslinked complex from binding filaments in copelleting assays, arguing 
against this mechanism (SI Appendix, Fig. S3). Finally, inhibition of spontaneous  
Figure 5 (next page): The short pitch crosslinked complex is more active than 
WASP-activated uncrosslinked complex.  
A. (Left panel) Coomassie stained SDS-PAGE gel showing the pre-crosslinked dual 
cysteine complex, the post crosslinking reaction, and the purified crosslinked complex 
after passing though a MonoQ column and a GST-Dip1 affinity column. (Right panel) 
Anti-Arp3 western blot of purified crosslinked and uncrosslinked samples. B. Time 
courses of 3 μM 15% pyrene actin polymerization for reactions containing 10 nM dual 
crosslinked cysteine ScArp2/3 complex (“xlinked Arp2/3”) or 10 nM uncrosslinked 
complex with either no NPF (“dual Cys Arp2/3”), 250 nM N-WASP-VCA or 50 nM 
GST-Las17-VCA, as indicated. Multiple reaction time courses are shown for the fastest 
reactions. C. Maximum polymerization rate versus NPF concentration for reactions 
containing 10 nM uncrosslinked complex with N-WASP-VCA, GST-Las17-VCA, or 
leucine-zipper dimerized N-WASP-VCA in conditions identical to panel B. The average 
maximum polymerization rate for purified crosslinked complex without NPFs is shown 
as a red circle. Error bar indicates the standard deviation (n=3).  D. Comparison of 
maximum polymerization and time to one half maximal polymerization for 10 nM 
crosslinked complex versus 10 nM uncrosslinked complex with 250 nM N-WASP-VCA. 
Error bars indicate the standard deviation (n=3).  E. Time course of polymerization of a 
reaction containing 3 μM 15 % pyrene labeled actin, 2.5 nM purified crosslinked 
complex, and 0-40 μM N-WASP-CA, as indicated.  F. Plot of the maximum 
polymerization rate versus N-WASP-CA concentration for reactions in E.  
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nucleation by WASP may also decrease the maximal polymerization rate even at optimal  
WASP concentrations, leading to greater activity of the short pitch crosslinked complex 
(16).  
Residues in the C region influence the ability of WASP to stimulate the short pitch 
conformational change 
How CA binding stimulates movement of Arp2 into the short pitch position is 
unknown. As a first step in dissecting the mechanism, we used the crosslinking assay to 
test the role of specific WASP-CA residues in stimulating the conformational change. 
The C consensus sequence is characterized by several conserved hydrophobic residues 
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(Fig. 6A)(31). NMR line broadening experiments and mutational analysis suggest these 
hydrophobic residues occupy one face of an amphipathic helix that forms when WASP 
binds Arp2/3 complex (31). Immediately C-terminal to the proposed amphipathic helix is 
a conserved arginine, R477 in WASP. The R477K (R478K in N-WASP) mutation is 
found in Wiskott-Aldrich syndrome patients and reduces WASP-mediated activation of 
Arp2/3 complex (Fig. 6B) (9, 40). This mutation decreased crosslinking ~2.5-fold at 
saturation compared to wild type N-WASP, demonstrating the importance of this residue 
in stimulating the short pitch switch (Fig. 6C, SI Appendix, Fig. S4, SI Appendix, Table 
S3). Previous data showed that another mutation within the C region, WASP L470A 
(L471A in N-WASP), decreased activity in polymerization assays and blocked a 
conformational change measured by FRET, suggesting this residue may be also important 
for stimulating the short pitch conformation (12, 31). Consistent with this hypothesis, the 
L471A mutation decreased short pitch crosslinking by ~3-fold compared to wild type N-
WASP-VCA (Fig. 6C).  These observations support a model in which contacts with the C 
region are critical for stimulating the short pitch conformation, and identify two key 
residues for stimulating this switch. 
The A region of WASP family proteins is characterized by a conserved 
tryptophan surrounded by several acidic residues (Fig. 6A). The A region confers most of 
the Arp2/3 complex binding affinity to WASP proteins (9). The acidic residues in A play 
an important role in branching nucleation kinetics. Specifically, deletion of acidic 
residues in N-WASP-VCA increases the affinity of N-WASP for the complex and 
decreases branching nucleation rates (19), whereas addition of acidic residues to WAVE1 
increases nucleation rates (30). To test the influence of the acidic residues in stimulating 
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the short pitch switch, we created a (monomeric) N-WASP construct with five acidic 
resides deleted from A. This construct stimulated crosslinking to the same extent as the 
wild type N-WASP-VCA (Fig. 6C, S3, SI Appendix, Table S3). Therefore, decreased 
activation of the complex by the N-WASP(ΔDEDED) mutant cannot be explained by a 
failure to induce the short pitch conformation, and instead is likely due to slow release of 
the N-WASP(ΔDEDED) from branch junctions (19).  
 
CA-fusion complexes suggest the N-WASP C region binds to the barbed end 
grooves of Arp2 and Arp3  
Our data demonstrate that CA regions from diverse WASP proteins stimulate the 
short pitch conformation, and that residues in the C region are critical for stimulating the 
switch. However, understanding how C stimulates this conformation requires knowledge 
of how C interacts with the complex. Based on biochemical and biophysical studies 
described above, WASP C has been proposed to interact with the barbed end grooves of 
Arp2 and Arp3 (25-27, 32, 34). The C-termini of Arp2 and Arp3 terminate between 
subdomains 1 and 3, filling the back portion of the barbed end grooves in a position that 
either overlaps or sits immediately adjacent to the predicted binding sites for C (20) (Fig. 
7). This arrangement provides a fortuitous opportunity to test the proposed binding mode. 
As described above, we created chimeric subunits in which the CA region of N-WASP is 
fused to the C-terminus of either Arp2 or Arp3 (Fig. 7A-C). Based on the proposed 
binding mode, the tip of the Arp3 C-terminus sterically overlaps the WASP C helix, so 
we truncated Arp3 by 7 residues, removing the tip of the C-terminal tail and connecting  
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Figure 6: Residues in the C region tune are important for stimulating the short pitch 
conformational change. 
A. Sequence alignment of WASP family CA regions. Conserved hydrophobic (green 
boxes) and basic (red boxes) residues are indicated, and acidic residues in the A region 
are boxed in cyan. N-WASP point mutations and deletion construct investigated in this 
study are indicated. Bt, Bos taurus; Hs Homo sapiens; Sc, Saccharomyces cerevisiae. B. 
Maximum polymerization rate versus NPF concentration for polymerization reactions 
containing 3 μM 15% pyrene actin, 10 nM dual cysteine Arp2/3 complex, and the 
indicated concentration of each NPF. C. Results of 1 min short pitch crosslinking 
reactions containing 1 μM dual cysteine Arp2/3 complex, 25 μM BMOE and the 
indicated concentrations (in μM) of mutant or wild type N-WASP-VCA. Error bars show 
standard error from three reactions. 
 
the base of the tail to the N-terminus of the N-WASP CA region with a short linker 
(GSG). We reasoned that fused CA would properly engage Arp3 only if the front of the  
barbed end grove is the correct binding site for C, as predicted by the model. A similar 
strategy was used for Arp2, except that the Arp2 C-terminus is shorter, so the binding 
model predicted that truncation of only three residues from the C-terminus would allow 
the C helix to fold into its predicted position in the groove (Fig. 7C).  
To determine if fused CA segments are properly engaged, we asked if they could 
compete with VCA for binding to the complex. To accomplish this, we first reacted the 
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bi-functional crosslinker benzophenone-4-maleimide (B4M) with N-WASP-VCA at an 
engineered cysteine residue (T464C) immediately N-terminal to the C region (Fig. 7D). 
We used UV radiation to crosslink this adduct, N-WASP-VCA-T464C-B4M, to the wild 
type complex, producing VCA crosslinked adducts of both Arp2 and Arp3, as expected 
based on previously published crosslinking studies (Fig. 7E,F) (28). Unlabeled VCA 
competes with N-WASP-VCA-T464C-B4M for crosslinking to the wild type complex at 
the Arp2 and Arp3 sites, demonstrating the reaction is specific. Importantly, the Arp3-CA 
fusion completely blocked N-WASP-VCA-T464C-B4M from crosslinking to Arp3 (Fig. 
7E-G). This result suggests that CA properly engages its site on Arp3 in the fusion 
chimera, providing support for a model in which the C-region binds the Arp3 barbed end 
groove. Fusion of CA to Arp3 did not influence N-WASP-VCA-T464C-B4M 
crosslinking to Arp2, indicating that the Arp3-CA fusion specifically blocks binding of 
CA to the Arp3 site. We repeated the B4M crosslinking experiments to test whether the 
Arp2-CA fusion engages the Arp2 CA binding site. Under our reaction conditions, 67% 
of Arp2 from wild type complex crosslinked to N-WASP-VCA-T464C-B4M, whereas 
only 4.3% of the Arp2 was crosslinked in the Arp2-CA chimera (Fig. 7E-G). This potent 
reduction in crosslinking demonstrates that CA fused to the C-terminus of Arp2 blocks 
the Arp2 CA binding site. Together these experiments support the proposed binding 
modes, in which the C region of WASP binds the barbed end groove of either Arp2 or 
Arp3. The proposed binding modes are also consistent with recent low-resolution x-ray 
crystal structures of Arp2/3 complex crystals grown in the presence of WASP-CA, which 
show putative electron density for WASP C bound to the barbed ends of Arp2 and Arp3 
(34).  
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Figure 7: WASP-CA fused to the C-terminus of Arp2 or Arp3 blocks binding of 
soluble WASP-VCA to the CA-fusion subunit  
A. Sequence alignment of the C-terminus of Arp2, Arp3 and actin, showing design of 
Arp CA-fusion constructs. Residues conserved in Arp2 and Arp3 (cyan boxes), Arp2 
only (pink boxes), or Arp3 only (green boxes) are indicated. Residues in Arp3 that mark 
the tip (blue line) and base (red line) of the Arp3 C-terminal tail are indicated.  The 
majority of residues from the fused CA segments were omitted from the alignment, 
indicated by “(CA)”.   B. Hypothetical model of Arp3-CA fusion structure. The fused CA 
sequence is shown in magenta, and the linker is in green. The model was constructed 
from the crystal structure of Arp2/3 complex with bound ATP (2P9K) (22), with the 
WASP C region modeled into position based on a WASP-V bound actin structure (2A3Z) 
(32). The A region was placed between subdomains 3 and 4 based on the structure 3TSE 
(27). C. Hypothetical model of Arp2-CA fusion structure. The model was constructed 
from the crystal structure of GMF-bound Arp2/3 complex (4J2D) (23), with WASP C 
modeled into position as described above. D. Schematic of benzophenone-4-maleimide 
(B4M) crosslinking assay to probe WASP-CA binding at each site on the complex. E. 
Anti-Arp3 western blot of B4M UV crosslinking reactions containing 1.5 μM dual 
cysteine (“wt”), Arp2-CA fusion, or Arp3-CA fusions complexes with 200 μM ATP and 
either no NPF, 4 μM N-WASP-VCA(T464C)-B4M or 100 μM leucine zipper dimerized 
VCA (LZ-VCA), as indicated. All three complexes harbor the dual cysteine engineered 
mutations.  F. Reactions from E run analyzed by western blotting with anti-Arp2 
antibody. G. Quantification of B4M crosslinking reactions as described in E and F. Error 
bars are standard errors from three reactions. 
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WASP C likely displaces the C-terminus from the barbed end groove of Arp3 to 
relieve autoinhibition and stimulate the short pitch conformation 
 How could WASP-CA stimulate the short pitch conformation? We analyzed 
crystal structures of inactive Arp2/3 complex in the context of the CA binding model to 
identify interactions that could potentially destabilize inter-subunit contacts important for 
holding the complex in the splayed conformation.  We also analyzed low resolution EM 
models of Arp2/3 complex at a branch junction to identify WASP-CA interactions that 
could stabilize the short pitch conformation (24). These analyses, in conjunction with 
results from a recently submitted study, led us to hypothesize that interactions of WASP-
C with the Arp3 barbed end groove are critical for stimulating the short pitch 
conformation. We recently found that the Arp3 C-terminus is an autoregulatory switch 
important for holding the complex inactive in the absence of NPFs (manuscript 
submitted). The Arp3 C-terminal tail engages the Arp3 barbed end groove and occupies a 
critical position at the splayed Arp2-Arp3 interface (Fig. 8A,B). The base of the Arp3 C-
terminal tail directly contacts Arp2 to stabilize the splayed conformation, whereas the 
most C-terminal residues in the Arp3 tail (the “tip”) do not directly contact Arp2, but 
instead fill the front portion of the barbed end groove (20-22). Deletion of the entire Arp3 
C-terminal tail in either budding or fission yeast Arp2/3 complexes stimulates the short 
pitch conformation and increases NPF-independent activity (submitted). Furthermore, 
mutations that disrupt interactions of the tip of the tail with the barbed end groove also 
stimulate the short pitch conformation (submitted), supporting a model in which release 
of the tip from the barbed end groove allosterically relieves autoinhibition by 
destabilizing the splayed Arp2-Arp3 interface (Fig. 8A). Importantly, our CA-fusion data, 
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along with recently published low resolution crystal structures (34), suggest WASP-C 
engages the barbed end groove of Arp3, where it would overlap with the tip of the C 
terminal tail (Fig. 7, 8A,B). Therefore, we hypothesized that WASP could activate the 
complex by displacing the Arp3 C-terminal tail from the Arp3 barbed end groove. To test 
this, we first asked if the C-terminus and WASP-CA compete for binding to the complex. 
We used fluorescence anisotropy to measure the affinity of rhodamine-labeled WASP 
proteins for the budding yeast and fission yeast Arp3ΔC complexes. Using a single-site 
binding model (see materials and methods and (27)), we found the affinity of rhodamine-
labeled WASP proteins increased four to six fold for the Arp3ΔC mutants compared to 
wild type complexes (Fig. 8C, SI Appendix, Fig. S5). To eliminate the influence of the 
rhodamine label, we ran competition assays to measure binding of unlabeled WASP 
proteins. These experiments showed that the Arp3ΔC complexes bind to WASP proteins 
4 to 13-fold more tightly than wild type complex (Fig. 8C). While the fluorescence 
anisotropy assay does not allow us to distinguish between binding to Arp2 or Arp3, we 
took advantage of the observation that truncation of the Arp3 C-terminus causes a 
previously unreactive endogenous cysteine in Arp3, C426, to react in the BMOE 
crosslinking assay (Fig. 8D). Arp3 C426 lines the barbed end groove (Fig. 8B), and 
deletion of the C-terminus allows this residue to crosslink with Arp2 to form a non-short 
pitch crosslink that migrates below the short pitch crosslinked Arp3-Arp2 adduct (Fig 
8D, SI Appendix, Fig. S6). We reasoned that if CA binds to the barbed end groove of 
Arp3, it could directly block the reactivity of C426. Consistent with this prediction, 
addition of CA to the Arp3ΔC complex decreased crosslinking between Arp2 and Arp3 
C426 (Fig. 8D). To provide additional evidence that WASP-C binds the barbed end of 
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Arp3, we asked if WASP-C could be directly crosslinked to C426 in Arp3. To this end, 
we designed a VCA construct (N-WASP-VCA(V468C)) with a cysteine residue 
immediately N-terminal to C (SI Appendix, Fig. S7). N-WASP-VCA(V468C) formed a 
disulfide crosslink with C426 in the Arp3ΔC complex in the presence of CuSO4 (Fig. 8E). 
The crosslinking was abolished by addition of cysteine-free N-WASP-CA, indicating that 
the crosslinking occurs between bound N-WASP-VCA(V468C) and Arp3. These data 
support a model in which WASP C directly competes with the Arp3 C-terminus to 
displace it from the barbed end groove, revealing a structural mechanism by which 
WASP binding can stimulate the short pitch conformation. However, we note that in the 
absence of high-resolution structures of Arp3 with bound WASP-CA, we cannot 
eliminate the possibility that competition is not direct, but instead involves an allosteric 
link between the WASP-CA binding site and the Arp3 C-terminus. 
 
Discussion 
Stimulating the short pitch conformation is a critical NPF function  
Previous models for activation of Arp2/3 complex ascribed two major functions 
for WASP: 1.) stimulation of an activating conformational change in the complex (11-13, 
15) and 2.) direct recruitment of actin monomers to assemble a nucleus consisting of 
Arp2, Arp3 and one or more actin monomers (9, 41). The relative contribution of each of 
these functions was unknown.  Here we show that locking Arp2/3 complex into the short 
pitch conformation potently activates it without NPFs, demonstrating that direct  
 76 
 
 
 
Figure 8: WASP competes with the Arp3 C-terminus for binding the barbed end 
groove of Arp3  
A. Model for relief of autoinhibition of Arp2/3 complex by WASP-CA binding. NBC, 
nucleotide binding cleft; T, tip of the Arp3 C-terminal tail; B, base of the Arp3 C-
terminal tail. Subdomains of Arp3 and Arp3 are numbered 1-4. B. Hypothetical model of 
WASP-CA (magenta) bound to Arp3 showing clash between WASP-C and the tip of the 
Arp3 C-terminal tail (yellow). Cysteine 426, a residue that becomes reactive when the C-
terminus is deleted, is shown in green spheres. Arp3 ribbon diagram is based on 1K8K, 
and WASP-C is modeled into barbed end groove of Arp3 based on WASP-V bound actin 
structure (2A3Z) (32). C. Tabulated results from fluorescence anisotropy binding assays. 
D. Two color (anti-Arp3/anti-Arp2, top) or one color (anti-Arp3, bottom) western blots of 
crosslinking reactions containing 1.0 μM wild type, Arp3ΔC or Arp3ΔC(C426A) fusions 
complexes (each with dual cysteine mutations) with or without 20 μM N-WASP-CA 
showing short pitch (sp) or non short pitch (non sp) products  E. Anti-Arp3 western blot 
of VCA crosslinking reactions containing 0.5 μM wild type, Arp3ΔC, or 
Arp3ΔC(C426C) S. cerevisiae Arp2/3 complex, 2 μM N-WASP-VCA(V468C), 50 μM 
CuSO4,10 mM Imidazole pH 7.0, 50 mM KCl, 50 μM EGTA, 1 mM MgCl2 and 200 µM 
ATP with or without 50 μM N-WASP-CA. Note that the Arp2/3 complexes in this assay 
lack the engineered cysteines for short pitch crosslinking.  
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monomer tethering is not required to assemble the nucleus, as previously anticipated. 
Therefore, whether or not direct actin monomer tethering is required for potent activation  
by any NPF likely depends on the identity and mechanism of the NPF, and is not a 
fundamental requirement of the branching nucleation reaction. Consistent with this 
hypothesis, WISH/DIP/SPIN90 (WDS) family proteins can potently activate Arp2/3 
complex but lack known actin monomer binding domains (5). While little is known about 
this class of NPFs, we previously used the crosslinking assay to show that WDS protein 
Dip1 stimulates formation of the short pitch conformation, and our data here suggest this 
is sufficient for Dip1-mediated activation of the complex (5). Like WDS family proteins, 
type II NPFs like cortactin and fission yeast myosin I interact with Arp2/3 complex and 
actin filaments but not actin monomers (37, 42-44). Unlike WDS proteins, type II NPFs 
are generally weak activators on their own (7). Recent experiments indicate that at least 
in the case of cortactin, this weak activity is due to an inability to directly deliver 
monomers to Arp2/3 complex (42). Type II NPFs typically interact with actin monomer 
binding proteins that allow them to indirectly deliver monomers to the complex and 
potently increase their ability to activate (7, 45, 46). Therefore, as with WASP, a 
requirement for actin monomer recruitment may be programmed into the activation 
mechanism of type II NPFs. An important future direction will be to determine why actin 
monomer recruitment is required for potent activation by some NPFs but not others, and 
how this requirement is structurally encoded into the activation mechanism.  
Here we propose a model in which WASP CA stimulates the short pitch 
conformation by displacing the Arp3 C-terminal tail from the barbed end groove, thereby 
triggering destabilization of the splayed conformation. Our data indicate this mechanism 
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must work coordinately with other activation triggers. For example, in a recent study, we 
provide evidence that ATP bound to the Arp3 nucleotide cleft allosterically disrupts 
interactions between the Arp3 tail and the barbed end groove, providing another 
mechanism to destabilize the splayed conformation (manuscript submitted).  Structural 
features other than the Arp3 C-terminal tail must also be involved in triggering activation. 
For example, here we showed that CA engagement with Arp2 is also important for 
stimulation of the short pitch conformation. In addition, phosphorylation of Arp2 near its 
interface with ARPC4/ARPC2 is required for activation of the complex in some species, 
and is thought to destabilize the splayed conformation (8, 47). Understanding how Arp2/3 
complex structurally integrates each of these activating responses remains an important 
open question in the field.  
 
The role of WASP, actin monomers and actin filaments in activation 
Because actin monomers, WASP and actin filaments are required to activate the 
complex in most contexts (4, 5, 9, 10), it has generally been assumed that cooperation 
between each of these factors is required to shift the conformation into the short pitch 
conformation, thereby stimulating activation.  Our data lead us to re-evaluate the 
relationship between activity and conformation. Specifically, the observation that WASP-
VCA (or CA) alone can stimulate crosslinking between short pitch engineered cysteines 
makes it unclear why WASP-recruited monomers and actin filaments are also required 
for activation. Because the crosslinking assay conformationally traps the complex, one 
possibility is that WASP-bound Arp2/3 complex may not significantly populate the short 
pitch state, but by crosslinking we amplify a functionally insignificant effect of WASP on 
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the concentration of short pitch complex. Previous experiments indeed demonstrate that 
WASP binding is not sufficient to fully populate the short pitch conformation, since 
WASP-recruited actin monomers potently increase the amount of short pitch crosslinking 
over reactions with WASP alone (11). However, comparisons of the relative amount of 
complex crosslinked under different conditions, while yielding no information about 
absolute equilibrium populations, indicate the bias toward the short pitch conformation in 
the presence of WASP alone should be functionally significant. Without WASP, only ~3 
% of the Arp2/3 complex was crosslinked after one minute of crosslinking, suggesting 
the complex only weakly adopts the short pitch conformation in the absence of NPF. 
However, this amount is functionally significant, since ScArp2/3 complex shows NPF-
independent activity in pyrene actin polymerization assays. Therefore, the ~7-10 fold 
increase in crosslinking stimulated by WASP-CA (or VCA) proteins without actin 
probably reports on functionally significant increases in the short pitch conformation. 
Several previously published biochemical and biophysical experiments agree with this 
interpretation, since they indicate that WASP alone causes a significant shift in the 
conformational equilibrium of the complex, presumably toward an activated state (12-
15). 
A second explanation for the insufficiency of WASP-CA in activation (despite its 
influence on the conformation of the complex) is that WASP-CA binding stimulates an 
intermediate conformation close to but distinct from the short pitch arrangement. Our 
data cannot not eliminate this possibility, since BMOE crosslinking may not necessarily 
strictly constrain the complex to the short pitch state, as noted above. From an 
intermediate WASP-CA stimulated conformation, WASP-recruited actin monomers and 
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filaments could trigger population of the “fully” short pitch state. However, recent EM 
reconstructions of negatively stained NPF-bound Arp2/3 complexes argue against 
intermediate WASP-bound conformations, since the particles segregated into only two 
different conformational classes (15). One class corresponded to the inactive “splayed” 
conformation seen in crystal structures, and the second (NPF-bound) class produced 
three-dimensional density consistent with a filament-like (short-pitch) arrangement of 
Arp2 and Arp3.  This study is in contrast with slightly lower resolution reconstructions of 
NPF-bound Arp2/3 complexes that indicated a third conformational class corresponding 
to an intermediate state (13). Thus, the precise structures of WASP bound complexes and 
their role in activation remain an important open question.  
Finally, another possibility is that actin filaments (and potentially WASP-
recruited monomers) could stimulate activating steps distinct from the adoption of short 
pitch conformation.  In addition to movement of Arp2 and Arp3 into the filament-like 
arrangement, the EM branch junction model describes intramolecular rearrangements 
within the Arp subunits that may be important for activation, and could be stimulated by 
actin filaments or monomers. This hypothesis is attractive given recent experiments 
suggesting that WASP must be released from nascent branch junctions for nucleation to 
occur (19, 37). Conformational changes initiated by filaments but distinct from the short 
pitch switch could help accelerate WASP release, potentially explaining the requirement 
for filaments in activation.  We anticipate that in addition to the engineered “short pitch” 
dual cysteine Arp2/3 complex, additional biophysical tools and high resolution structures 
will be required to dissect the conformational pathway to activation, including the 
molecular basis for WASP release.  We note that our data provide two new observations 
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that may be important for understanding the release mechanism. First, while previous 
studies used single molecule TIRF to show WASP release triggers nucleation, these 
studies used only dimeric WASP proteins (19). Experiments here indicate slow 
detachment of monomeric WASP proteins might also limit branching rates. Second, 
previous structural models suggested that the WASP V region blocks monomers from 
associating with nascent branch junctions (32, 37), explaining the requirement for WASP 
release. Here we show that CA alone stalls nucleation, demonstrating that the structural 
features that program WASP release into the nucleation mechanism are more 
complicated than previously anticipated. 
 
Role of WASP engagement at each binding site 
We show that engagement of WASP-CA with Arp3 is critical for stimulating the short 
pitch conformation. However, experiments with the CA fusion complexes revealed that 
engagement of WASP-CA at the Arp2-ARPC1 site is also important for this 
conformational change. WASP engaged at this site likely uses a mechanism other than C-
terminal tail displacement, because unlike Arp3, the Arp2 C-terminus does not make 
contacts that stabilize the splayed (inactive) conformation (20-23). ITC binding 
measurements show a ten fold difference in the binding affinity at each of the two 
WASP-CA binding sites (26, 27), and it will be important to determine how the 
asymmetry in binding affinities influences the reaction kinetics. We note that our studies 
indicate that Arp3 harbors the high affinity site, because the fluorescence anisotropy 
binding assay measures binding to the high affinity site (27), and affinities measured by 
this method increased when competition with the Arp3 C-terminal tail was eliminated. 
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This conclusion is in agreement with other studies that indicate the high affinity site is on 
Arp3 (48). However, some experiments point to the Arp2-ARPC1 site as the high affinity 
site (26, 27, 33). For instance, a recent ITC study directly demonstrated that WASP 
delivers actin monomers to the Arp2 site first, suggesting that at least in the presence of 
monomers, the Arp2 site is the higher affinity site (49). While the complexity of this 
issue has precluded a clear consensus on the issue, we speculate that the preferred 
binding site may depend on whether or not WASP is bound to actin monomers.  
 
BRIDGE TO CHAPTER IV 
 In this chapter, we demonstrated that diverse type I NPFs are capable of 
stimulation of the short pitch conformation and that binding of these NPFs to either the 
Arp2 or Arp3 site is important for activation of the complex, and determined which 
residues in N-WASP are important for this conformational change. We showed that 
WASP likely binds to the barbed end grooves of each Arp and that displacement of the 
Arp3 C-terminus by WASP is a mechanism for how this protein activates Arp2/3 
complex. Remarkably, we showed that Arp2/3 complex locked into the short pitch 
conformation is hyperactive compared to NPF-activated complex, which is likely due to 
release of WASP from the complex stalling nucleation rates. In the next chapter, I 
summarize the results from the entirety of my dissertation, and discuss some future 
directions from this work.  
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CHAPTER IV 
 
SUMMARY AND CONCLUDING REMARKS 
Coordinate regulation of branched actin networks has been an exciting field of 
research for over a decade. Many roles for Arp2/3 complex and its regulators have been 
identified throughout the years, but biochemically dissecting how NPFs activate the 
complex still requires more research. At the beginning of this project, we were motivated 
to contribute to the research on branched actin networks by understanding how Arp2/3 
complex is locked in its inactive state in the absence of NPFs, and how NPFs promote an 
activating conformational change where Arp2/3 complex mimics a stable actin dimer that 
templates growth of a new branched actin filament. 
In chapter II, we dissected the contacts in Arp2/3 complex that hold it in its 
inactive conformation and how ATP destabilizes some of these contacts to promote 
activation of the complex. We hypothesized that the Arp3 C-terminus is an important 
regulatory element that holds the complex in its inactive state, where the “base” of the C-
terminus stabilizes the splayed conformation by contacting subdomain 4 of Arp2 and the 
“tip” of the C-terminus is wedged in the barbed end groove of Arp3, forming an allosteric 
link that promotes opening of the nucleotide cleft. To test this hypothesis, we truncated 
the C-terminus in S. pombe and S. cerevisiae Arp2/3 complexes and biochemically 
characterized them. We found that the Arp3ΔC complexes displayed NPF-independent 
activity with the S. cerevisiae complex showing a profound increase in bulk actin 
polymerization assays. We showed that this effect is due to favoring the short pitch 
conformation using a crosslinking assay that only form when Arp2/3 complex is in this 
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conformation. To see if removal of the C-terminus had an effect in vivo, we monitored 
endocytic patches in wild type and Arp3ΔC S. pombe cells. Patches in Arp3ΔC cells 
displayed longer lifetimes with decreased assembly and disassembly rates. This caused a 
functional defect in endocytosis, as shown by the relative lack up uptake of the dye FM4-
64. This data shows that deletion of the Arp3 C-terminus has functional consequences in 
vitro and in vivo. The Arp2 αE/αF loop in subdomain 4 forms contacts with Arp3 in the 
inactive structure, yet we did not predict that it forms significant contacts in the short 
pitch conformation, so we posited that this region is important for holding Arp2/3 
complex in the splayed conformation. To test this hypothesis, we made point mutations in 
positions F203 and A207 and found that destabilizing this region caused activation of the 
complex, as measured by both polymerization and short pitch crosslinking assays. 
Since ATP binding promoted closing of nucleotide cleft and release of the tip of 
the C-terminus in crystal structures, we hypothesized that ATP is required for stimulation 
of the short pitch conformation. In the absence of ATP, we detected no short pitch 
crosslinking, indicating that ATP is required for the short pitch conformation. We tested 
point mutants in either Arp2 or Arp3 nucleotide binding cleft and showed that mutants 
defective in binding ATP at either the Arp2 or Arp3 site formed significantly less short 
pitch crosslinking, with mutations at the Arp2 site forming no detectable crosslinks, 
indicating that binding of ATP to the Arp2 site plays a larger role in short pitch 
stimulation. When we tested the requirement of ATP with the Arp2 αE/αF and Arp3ΔC 
mutants, we found that each mutant still required ATP for short pitch crosslinking, with 
only two mutants (F203Y and A207C) forming any detectable crosslinks in the absence 
of ATP. To test if removal of the C-terminus promoted closing of the nucleotide cleft, we 
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performed binding assays with the ATP analog, etheno-ATP (ε-ATP). We found that the 
S. pombe Arp3ΔC complex had a ~2.7-fold increase in affinity for ε-ATP, however this 
effect was not seen in the S. cereivisiae complex, although this could to be due to ε-ATP 
failing to form the same allosteric link as ATP. This data indicates that ATP binding 
causes allosteric changes that causes destabilization of the splayed conformation, 
favoring the short pitch conformation.  
We showed that deletion of the C-terminus causes pronounced effects on the 
conformation and activity of Arp2/3 complex, and that binding of ATP to the Arp3 
nucleotide binding pocket causes closing of the nucleotide cleft and release of the tip of 
the C-terminus from the Arp3 barbed end groove. To isolate the effects of binding of the 
tip of the C-terminus to the Arp3 nucleotide cleft, we used a more conservative approach 
where we mutated two conserved hydrophobic residues that form the most significant 
contacts between these two regions. Mutation of L445 and F446 to glutamic acid 
moderately increased activity of Arp2/3 complex in polymerization and crosslinking 
assays, indicating that release of the tip of the C-terminus alone causes the complex to 
favor the short pitch state. Interestingly, we observed in our crosslinking assays that 
deletion of the C-terminus exposes an endogenous cysteine, Arp3 C426, causes a non-
short pitch crosslink that also appears in the LF/DD mutant, providing further evidence 
the a model where release of the Arp3 C-terminus stimulates the short pitch 
conformation, providing a mechanism as to how ATP relieves autoinhibition of Arp2/3 
complex.  
In chapter III, we shifted our focus to the mechanisms of WASP-mediated 
activation of Arp2/3 complex. Since there are many WASP-related NPFs, we first 
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demonstrated that the conserved VCA regions from these proteins all were capable of 
potently stimulating the short pitch conformation. To biochemically characterize Arp2/3 
complex in the short pitch conformation, we designed WASP-Arp chimeras where the 
CA region of N-WASP was fused the C-terminus of either Arp2 or Arp3 to isolate 
Arp2/3 complex that constitutively favors the short pitch conformation. Unexpectedly, 
the Arp-CA chimeras only slightly increased short pitch crosslinking in the absence of 
exogenous CA. One chimera, Arp2-CA, had a very modest increase in activity over wild 
type complex, while Arp3-CA showed decreased nucleation rates. When CA was added 
to these complex, we observed a similar degree of crosslinking to wild type complex with 
added CA, indicating that CA binding to both sites is important for full stimulation of the 
short pitch conformation. Interestingly, addition of CA to wild type and Arp-CA 
complexes inhibited nucleation in polymerization assays, demonstrating for the first time 
that CA alone stalls nucleation rates due to lack of release by CA, despite structural 
modeling suggesting that the V region blocks association of new actin monomers, 
necessitating release of VCA.  
Due to the complicated effects of the Arp-CA chimeras, we sought to use the 
short pitch crosslinked complex to understand the role of the short pitch conformation. 
We found that crosslinking caused potent activity, even in the absence of WASP, 
demonstrating that once locked into the short pitch conformation, Arp2/3 complex no 
longer needs WASP for activation. Since WASP also recruits actin monomers, 
presumably to stabilize the nascent nucleus, we sought to compare the activity of the 
crosslinked complex versus WASP-activated complex. This required pure crosslinked 
complex, which we successfully purified using an affinity column charged with GST-
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Dip1, which binds the crosslinked complex with higher affinity. Comparison of purified 
crosslinked complex versus WASP-activated complex showed that the crosslinked 
complex had much higher nucleation rates versus uncrosslinked, WASP-activated 
complex. This surprising result suggested that monomer recruitment is not required for 
stabilization of the nucleus and that WASP release stalls nucleation. Consistent with this 
model, WASP-CA decreased nucleation rates of the crosslinked complex. 
To biochemically dissect the mechanism for WASP-mediated stimulation of the 
short pitch conformation, we first investigated the residues important for full stimulation 
of the short pitch conformation. While mutations of residues in the C region and removal 
of acidic residues in the A region both decreased nucleation rates compared to wild type 
N-WASP-VCA, only the mutations in the C region caused a decrease in short pitch 
crosslinking, indicating that the C region is important for simulation of the short pitch 
conformation, while activity caused by residues in the A region is due to a different 
mechanism, such as release from the complex. Since residues in the C region are 
important for stimulation of the short pitch conformation, we wished to characterize how 
the C region contacts the Arp subunits. The C region is predicted to form an amphipathic 
helix similar to how the V region engages the barbed end groove of actin, so we predicted 
the C region binds in a similar fashion to the Arp subunits. Using the Arp-CA chimeras, 
we demonstrated that the fused CA at each subunit blocks association with exogenous 
CA, allowing us to isolate CA binding to each site. Using VCA with the C region labeled 
with B4M, we demonstrated that binding of VCA to each site caused crosslinking to their 
respective Arp subunits, supporting the hypothesis that the C region engages the barbed 
end grooves of Arp2 and Arp3.  
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The model where the C regions bind the barbed end grooves of Arp2 and Arp3 
suggests that CA competes with the C-terminus of Arp3 for binding in this region. 
Consistent with this hypothesis, WASP had a 4 to 6-fold increase in affinity to Arp3ΔC 
complexes compared to wild type. Consistent with the previous experiments, addition of 
CA prevented crosslinks to C426, the endogenous cysteine that lines the barbed end 
groove of Arp3. We provided additional evidence that the C region engages the barbed 
end groove by directly crosslinking Arp3 C426 with CuSO4 to a VCA construct with a 
cysteine introduced in the N-terminal portion of the C region. This data strongly suggests 
that WASP CA competes for the Arp3 C-terminus at the barbed end groove to promote 
activation of the complex. 
In this dissertation, we provided evidence that the splayed interface contacts are 
important for hold Arp2/3 complex in its inactive state, and that ATP and WASP promote 
relief of the autoinhibition of the complex by displacing the Arp3 C-terminus from the 
barbed end groove of Arp3. Future direction will be focused on determining the effects of 
actin monomer recruitment by WASP and the role of actin filaments in the branched actin 
nucleation pathway. Since we showed that actin monomer recruitment was not required 
once Arp2/3 complex was locked in the short pitch conformation, further work still needs 
to be done on why monomer recruitment is important for short pitch stimulation, and 
therefore activation. In addition, our data is consistent with previous data suggesting that 
while WASP, ATP and actin monomers potently stimulate the short pitch conformation, 
actin filaments are still required for branch formation, indicating that filaments are likely 
involved in a sequential process. Biochemically determining the requirement for actin 
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filaments will help explain why Arp2/3 complex is exclusively a branched actin 
nucleator.  
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APPENDIX A 
SUPPLMENTARY MATERIAL FOR CHAPTER II 
 
 
Supplementary Figure 1 | Coomassie-stained gel of purified wild type and Arp3ΔC 
complexes from budding and fission yeast.  
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Supplementary Figure 2 | Analysis of potential contacts of Arp3 C-terminus with 
Arp2/3 complex in the short pitch conformation at a branch.  
(Left panel) Model of Arp3 and Arp3 in the short pitch and splayed conformations. The 
hypothetical short pitch model was created by superposing the actin filament model of 
Oda, et al (2ZWH) (1) onto the Arp3 subunit of 1K8K. The splayed model shows Arp2 
from 4JD2 overlaid onto Arp2 from 1K8K. The Arp3 C-terminus is shown in yellow 
stick representation. R441 and N442 (ScArp3 residue IDs are used in this figure) are key 
residues from the base of the Arp3 C-terminal tail that contact Arp2 in the splayed 
conformation. (Right panel) Same analysis as in left panel, except that all subunits are 
taken from the electron tomography model of Arp2/3 complex at a branch junction (2). 
Arp2 is further from Arp3 in this model.  
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Supplementary Figure 3 | Ribbon diagram showing positions of engineered cysteine 
residues and splayed interface mutations in splayed or short pitch conformations. 
(Left panel) Arp2/3 complex in the splayed conformation from the structure of Arp2/3 
complex bound to GMF (4JD2) (3). Splayed interface mutations and engineered cysteine 
residues are shown in ball-and-stick representation. Engineered cysteine residues 
(highlighted in cyan clouds) are on opposite sides of the complex in the splayed 
conformation and the solvent accessible crosslinking distance is 32.5 Å (Cβ-Cβ)(4). 
Dashed line shows the approximate location of the splayed Arp2-Arp3 interface. (Right 
panel) Hypothetical model of Arp2/3 complex in the short pitch conformation. Model 
was constructed by overlaying actin filament from Oda, et al, (1ZWH) (1) onto Arp3 
from 1K8K and moving Arp2 from 4JD2 into the short pitch position. The solvent 
accessible crosslinking distance between the engineered cysteine residues is 8 Å in this 
model (Cβ-Cβ). The electron tomography structure of Arp2/3 complex at a branch 
junction shows similar overall positioning of Arp2 and Arp3 but using that model the 
solvent accessible crosslinking distance between the engineered cysteines is 11.3 Å (2) 
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Supplementary Figure 4 | Purification and activity of Arp2 and Arp3 nucleotide 
binding cleft (NBC) mutant Arp2/3 complexes. 
(a) Coomassie stained gel of purified wild type and NBC S. cerevisiae mutant Arp2/3 
complexes. Asterisks indicates possible Arp3 degradation as previously reported (6).  (b) 
Maximum polymerization rates calculated from time courses of pyrene actin 
polymerization for reactions containing 3 μM 15% pyrene actin, 250 nM N-WASP-VCA, 
500 μM ATP and the indicated concentrations of ScArp2/3 complex. Note that all 
complexes harbor the dual cysteine residues for short pitch crosslinking. (c) Maximum 
polymerization rates versus Arp2/3 complex concentration for reactions identical to b, 
except higher concentrations of Arp2/3 complex were used.  
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Supplementary Figure 5 | ε-ATP binding assays.  
Plot of background subtracted fluorescence versus ε-ATP concentration for reactions 
containing 0.5 μM S. pombe (a) or S. cerevisiae Arp2/3 complex. Data were fit assuming 
one binding site as described in the methods. 
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Supplementary Figure 6 | The width of the nucleotide binding cleft is correlated to 
the release of the C-terminal tail in Arp2/3 complex crystal structures.  
(related to Fig 7a in the main text) Left panels show a plot of average main chain B-factor 
versus residue number for the C-terminal residues in Arp3. Table on right indicates 
distances across the cleft, ligand bound, and classification of cleft closure. Data are taken 
from ten different Bos taurus (Bt) Arp2/3 complex crystal structures in different 
nucleotide-bound states (1K8K, 2P9L, 1U2V, 2P9N, 2P9U, 2P9P, 1TYQ, 2P9I, 2P9K, 
2P9S) (14-16). Nucleotide cleft widths are classified based on Nolen and Pollard (16).  B-
factors were normalized so that each chain had the same average main chain B-factor. 
Residues missing in the electron density are omitted from the plot. Residue numbers in 
parenthesis are for ScArp2/3 complex. B – base of Arp3 C-terminal tail, T- tip of C-
terminal tail.  
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Supplementary Figure 7 | An endogenous cysteine in Arp3, C426, becomes exposed 
and reactive upon deletion or mutation of the Arp3 C-terminal tail.  
Structure of Arp3 from BtArp2/3 complex crystal structure (4JD2) showing the C-
terminal tail (yellow), the two conserved hydrophobic residues in the tail (L445/F446 in 
S. cerevisiae Arp3, yellow sticks) and C426 (ball and stick).  
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Supplementary Figure 8 | Structural visualization of contacts that hold Arp2/3 
complex in the splayed conformation in the absence of activators.  
Structure of Arp3 and Arp3 in the short pitch conformation from the x-ray crystal 
structure of GMF-bound BtArp2/3 complex (4JD2) (3). ARPC1, ARPC2, ARPC4 and 
ARPC5 form a clamp (grey surface representation) that contacts Arp2 and Arp3 in the 
splayed conformation. The approximate location of the splayed interface between Arp2 
and Arp3 is indicated with a solid grey line. 
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Supplementary Figure 9 | Validation of purification procedure for Arp3ΔC 
complexes.  
Anti-GST Western blot of Arp3ΔC S. pombe (Sp) and S. cerevisiae (Sc) Arp2/3 
complexes verses GST-VCA standard. No GST-VCA is detectable in any of the purified 
complexes. Under the conditions of the loading, GST-VCA band in any of the purified 
samples (1-5) with the same intensity as the 0.5 ng GST-VCA standard would correspond 
to ~0.7 nM dimeric GST-VCA in a 1 μM solution of the purified complex. Sample 5 was 
not re-purified through the glutathione sepharose affinity column because no full length 
GST-VCA contaminant was present. We conclude that the lower molecular weight bands 
(asterisks) are C-terminal truncations of GST-VCA because 1.) They elute from the 
monoQ much earlier than full length GST-VCA, consistent with truncation of the acidic 
region and 2.) They bind to the glutathione sepharose affinity column.  
 
 
 
Supplementary Movie 1: Spinning disk confocal fluorescence microscopy movie of 
fission yeast expressing Fim1p-GFP and wild type Arp2/3 complex. Frames are taken 
at 0.5 sec intervals and length of entire movie is 120 seconds. 
 
Supplementary Movie 2: Spinning disk confocal fluorescence microscopy movie of 
fission yeast expressing Fim1p-GFP and Arp3ΔC Arp2/3 complex. Frames are taken 
at 0.5 sec intervals and length of entire movie is 120 seconds. 
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Supplementary Table 1 | Calculated pKa and solvent accessible surface areas for 
engineered cysteine residues in the context of the short pitch conformation of Arp2/3 
complex. 
 
SASA = solvent exposed surface area. pKa calculations were carried out using H++ and 
SASA calculations were made with POPS (7, 8)  
 
Supplementary Table 2 | Table of p-values for Figure 5E. 
 WT A207C A207W A207I F203Y 
WT  p < 0.001 p < 0.001 0.049 p < 0.001 
A207C   n.s. p < 0.001 p < 0.001 
A207W    p < 0.001 p < 0.001 
A207I     p < 0.001 
F203Y      
n.s. = non-significant. p-values calculated as two-tailed t-test comparing means of at least 
three experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 predicted pKa SASA (Å)2 
WT   
Arp3-L155C > 12.0 98.7 
Arp2-R198C > 12.0 53.4 
F203Y   
Arp3-L155C > 12.0 98.7 
Arp2-R198C > 12.0 53.4 
A207C   
Arp3-L155C > 12.0 98.7 
Arp2-R198C > 12.0 53.4 
A207W   
Arp3-L155C > 12.0 98.7 
Arp2-R198C > 12.0 53.4 
Arp3ΔC   
Arp3-L155C > 12.0 98.7 
Arp2-R198C > 12.0 53.4 
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Supplementary Table 3 | Table of p-values for Figure 6C. 
 
 WT 
Arp3 
(G358Y) 
Arp2 
(G305Y) 
Arp2 
(D10A) 
 
 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
WT 
No 
ATP 
 
p < 
0.001 
n.s. 
p < 
0.001 
n.s. n.s. n.s. n.s. 
With 
ATP 
  
p < 
0.001 
0.02 
p < 
0.001 
0.001 0.001 
p < 
0.001 
Arp3 
(G358Y) 
No 
ATP 
   
p < 
0.001 
n.s. n.s. n.s. n.s. 
With 
ATP 
    
p < 
0.001 
p < 
0.001 
p < 
0.001 
p < 
0.001 
Arp2 
(G305Y) 
No 
ATP 
     n.s. n.s. n.s. 
With 
ATP 
      n.s. n.s. 
Arp2 
(D10A) 
No 
ATP 
       n.s. 
With 
ATP 
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Suplementary Table 4 | Table of p-values for Figure 6D. 
 
 WT A207C A207W F203Y 
Arp3ΔC 
(C426A) 
 
 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
No 
ATP 
With 
ATP 
WT 
No 
ATP 
 0.036 0.009 0.037 0.040 0.007 0.013 
p < 
0.001 
0.024 0.004 
With 
ATP 
  0.062 0.023  n.s. 0.014 0.022 
p < 
0.001 
n.s. 0.006 
A207C 
No 
ATP 
   n.s. 0.012 n.s. n.s. 0.0014 0.035 n.s. 
With 
ATP 
    0.044 n.s. n.s. 0.021 n.s. n.s. 
A207W 
No 
ATP 
     0.009 0.015 
p < 
0.001 
n.s. 0.004 
With 
ATP 
      n.s. 0.007 0.018 n.s. 
F203Y 
No 
ATP 
       0.016 0.028 n.s. 
With 
ATP 
        
p < 
0.001 
0.033 
Arp3ΔC 
(C426A) 
No 
ATP 
         0.009 
With 
ATP 
          
 
n.s. = non-significant. p-values calculated as two-tailed t-test comparing means of at least 
three experiments. 
 
 
 
 
Supplementary Table 5 | List of fission yeast strains used. 
Strain Genotype Source 
BN024 leu1-32 sm902 arp3∆416-427::kanMX6 This study 
BN052 leu1-32 sm902 arp3∆416-427::kanMX6 
mEGFP-fim1::natMX6 
This study 
TP150 h- leu1-32 sm902 M. Yanagida 
TP194 h-  ade6-M216  leu1-32  his3-D1  ura4-D18 
∆wsp1::kanMX6   
V. Sirotikin 
 
 
 
 
 
 
 
 
 
 
 
 102 
 
 
Supplementary Table 6 | List of budding yeast expression plasmids used. 
Name Gene Vector 
pDW6 ARP2  pRS316 
pDW20 ARP3-MYC-HISx6 pRS316 
pCE04 ARP2 pRS305 
pCE05 ARP3 pRS305 
pBN01 ARP2 pRS317 
pBN02 ARP3 pRS315 
pBN03 arp2 R198C pRS317 
pBN09 arp3 L155C pRS315 
pMR01 arp2 R198C, A207C pRS317 
pMR02 arp2 R198C, A207I pRS317 
pMR03 arp2 R198C, A207W pRS317 
pMR04 arp2 R198C, F203Y pRS317 
pMR09 arp3∆Cterm440-449, L155C pRS315 
pMR14 
arp3∆Cterm440-449, 
L155C,C426A pRS315 
pMR17 arp3 L155C,L445D,F446D pRS315 
pMR18 arp2 D10A, R198C pRS317 
pMR20 arp2 R198C, G305Y pRS317 
pMR22 arp3 L155C, G358Y pRS315 
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Supplementary Table 7 | List of budding yeast strains used. 
Strain Genotype Source 
KEBY88 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, suc2-∆9, pep4-3  T. Stevens 
RLY188 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, ∆arp3::HIS3, pDW20::URA3 R. Li 
BN002 MATa, ura3-52, his3-Δ200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 pDW6::URA3 (9) 
BN021 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 ∆arp3::HIS3  
pBN09::LEU2, pBN03::LYS2 (9) 
MR001 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pDW20::URA3  This study 
MR002 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pMR01::LYS2 This study 
MR003 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pMR02::LYS2 This study 
MR004 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pMR03::LYS2 This study 
MR005 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pMR04::LYS2 This study 
MR010 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pBN09::LEU2 This study 
MR012 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR09::LEU2 This study 
MR016 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pBN03::LYS2 This study 
MR017 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3,  
pBN09::LEU2, pMR01::LYS2 This study 
MR018 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3,  
pBN09::LEU2, pMR02::LYS2 This study 
MR019 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3, 
pBN09::LEU2  pMR03::LYS2 This study 
MR020 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3,  
pBN09::LEU2  pMR04::LYS2 This study 
MR022 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3,  
pBN03::LYS2  pMR09::LEU2 This study 
MR030 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR14::LEU2 This study 
MR032 
MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3,  
pBN03::LYS2, pMR14::LEU2 This study 
MR034 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pMR18::LYS2 This study 
MR035 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pMR20::LYS2 This study 
MR037 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR22::LEU2 This study 
MR040 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3, 
pBN003::LYS2, pMR17::LEU2 This study 
MR041 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3, 
pBN003::LYS2, pMR18::LEU2 This study 
MR042 
MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3, 
pBN003::LYS2, pMR20::LEU2 This study 
MR044 
MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3,  
pBN003::LYS2, pMR22::LEU2 This study 
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APPENDIX B 
SUPPLEMENTARY MATERIAL FOR CHAPTER III 
 
Fig. S1: Analysis of crosslinking distances between the engineered cysteines along 
the trajectory from the splayed to the short pitch conformation.  
A. Ribbon diagram showing the relative position of Arp3 (orange) and Arp2 (splayed, 
semi-transparent red; short-pitch, semi-transparent grey) in the trajectory from the 
splayed to short pitch conformation. The engineered cysteine residues are shown in ball-
and-stick representation and highlighted in cyan. Blue spheres represent the center of 
mass of Arp2 throughout the trajectory. Sphere numbers represent the relative Arp2 
position within the trajectory (1-fully splayed, 30 – fully short pitch). B. Plot of the 
solvent accessible surface distance between the engineered cysteine residues for each 
structure along the trajectory. Trajectories (morphs) were generated using the short pitch 
conformation observed in the low resolution branch junction model (EM-model) (1), or 
derived from a model in which an actin filament structure was used to align the Arps in 
the short pitch conformation (“actin” model) (2). 
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Fig. S2: Separation of crosslinked and uncrosslinked complex by binding to GST-
Dip1 coated beads.  
Dual cysteine Arp2/3 complex (1 μM) was reacted with 25 μM BMOE for 30 min and 
incubated with GST-Dip1 coated glutathione sepharose beads at the indicated KCl 
concentration before pelleting and analysis by SDS-PAGE and western blotting with an 
Arp3 antibody. S-soluble, P-pellet. 
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Fig. S3: Actin filament copelleting assay showing that N-WASP CA does not block 
crosslinked Arp2/3 complex from binding actin filaments.  
A. Anti-Arp3 western blot showing copelleting of 0.1 μM purified crosslinked complex 
with 5 μM actin filaments and 20 μM N-WASP-CA where indicated. S-soluble, P-pellet. 
B. Fraction of Arp2/3 complex in actin pellet from data in A. Error bars show standard 
errors from three separate reactions. ***, p<0.0005. 
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Fig. S4: Time course of short pitch crosslinking assays comparing wild type versus 
mutant N-WASP proteins.  
Reactions contained 1 μM dual cysteine Arp2/3 complex, 25 μM BMOE, and 50 μM wild 
type or mutant N-WASP-VCA proteins. Reactions were quenched at the times indicated 
with 1 mM DTT and analyzed by SDS-PAGE and western blotting with an anti-Arp3 
antibody. Asterisk indicates time point used for experiments shown in Fig. 6C in the main 
text. 
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Fig. S5: Fluorescence anisotropy binding assays to investigate interaction of WASP 
proteins with wt and Arp3ΔC Arp2/3 complexes.  
A. Binding isotherms from fluorescence anisotropy binding assays. Main panel shows 
measured anisotropy values for titration of 0.5 μM wild type S. pombe Arp2/3 complex 
and 75 nM Wsp1-Rh-VCA with unlabeled Wsp1-VCA. Inset shows anisotropy values for 
titration of 75 nM Wsp1-Rh-VCA with S. pombe Arp2/3 complex. B. Binding isotherms 
for reactions identical to C, except 0.3 μM  S. pombe Arp3ΔC complex was used.  C. 
Main panel shows measured anisotropy values for titration of 0.2 μM wild type S. 
cerevisiae Arp2/3 complex and 30 nM N-WASP-Rh-VCA with unlabeled N-WASP-
VCA or N-WASP-CA. Inset shows anisotropy values for titration of 30 nM Wsp1-Rh-
VCA with S. cerevisiae Arp2/3 complex. D. Binding isotherms for reactions identical to 
C, except 0.1 μM S. cerevisiae Arp3ΔC complex was used.   
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Fig. S6 (next page): Hypothetical molecular models showing engineered and 
endogenous cysteine residues in Arp2 and Arp3. 
Stereo ribbon diagrams of Arp3 (orange) and Arp2 (red) showing the positions and Cα 
Euclidian distances between engineered Arp2 cysteine R198C and Arp3 engineered and 
endogenous cysteine residues L155C and C426. Endogenous cysteine residues (green 
carbon atoms and yellow sulfur) are buried and inaccessible. Top pair shows Arp2 and 
Arp3 in the splayed conformation (based on structures 1K8K and 4JD2) and bottom pair 
shows the proposed short pitch arrangement. The solvent accessible crosslinking 
distances between Arp3 C426 and Arp2 R198C are 28.6 Å in the splayed conformation 
and 45.4 Å in the short pitch conformation (3). This analysis indicates that the crosslink 
between Arp2 and Arp3 C426 (Fig. 8) is a non-short pitch crosslink and likely involves 
R198C in Arp2.  
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Fig. S7: Hypothetical molecular model showing the relative positions of V468C in N-
WASP-VCA relative to the reactive cysteine (C426) in the Arp3ΔC Arp2/3 complex.  
Ribbon diagram of Arp3 (orange) based on crystal structure 1K8K, with CA (magenta) 
modeled into the proposed binding site as described in Fig. 8 in the main text. Cysteine 
residues that crosslink in the CuSO4 crosslinking assay are shown in ball-and-stick 
representation. Subdomains of Arp3 are numbered. Segment of Arp3 C-terminus that is 
deleted in the Arp3ΔC Arp2/3 complex is yellow.  
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Supplemental Materials and Methods: 
 
Construction of budding yeast plasmids for Arp2/3 complex expression 
S. cerevisiae ARP2 and ARP3 including ~200-250 (203 for Arp2 / 252 for Arp3) 
upstream and ~150 (179 for Arp2 / 147 for Arp3) nucleotides downstream were 
subcloned from pCE04 and pCE05 (gift from Rong Li) into pRS317 and pRS315, 
respectively, to make vectors pBN01 and pBN02 (Table S5). Arp2(R198C) and 
Arp3(L155C) were introduced into pBN01 and pBN02 by the Quick Change PCR 
protocol and subcloned into pRS317 and pRS315, respectively. Arp3ΔC440-449 and 
Arp3ΔC440-449(C426A) were created using the same method in the context of either wild 
type or dual-cysteine mutations. CA-fusion constructs were generated by overlap 
extension PCR.  A bovine N-WASP-CA467-505 fragment was amplified using primers 
containing linker sequences along with sequences that overlapped the regions in the 
arp2(R198C) and arp3(L155C) genes targeted for insertion. Mutant plasmids were 
confirmed by sequencing.  
 
Construction of budding yeast strains 
Strain RLY188 (a gift from Rong Li, Stowers Institute) was crossed with strain KEBY88 
and sporulated to create ScMR001, a strain with the trp1-901 mutation and ARP3 
knocked out with the HIS3 marker and rescued with a ARP3::URA plasmid (pDW20) 
(See Tables S4 and S5). Arp2 or Arp3 expression plasmids were transformed into strains 
ScBN002 and ScMR001, respectively, and plated on the appropriate selective media 
(Leu- or Lys-) to select for the expression plasmid. URA plasmids containing wild type 
ARP2 or ARP3 were subsequently kicked out by plating on 5-Fluoroorotic acid. Resulting 
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single cysteine haploids expressing mutant but not wild type Arp2 or Arp3 were mated 
and diploids plated on synthetic medium lacking leucine, tryptophan, lysine and histidine. 
Sporulated diploids were analyzed by random spore analysis to select for the LEU, LYS, 
HIS and TRP markers. Final strains were confirmed as haploids by mating with tester 
strains and the expression plasmids were isolated and resequenced. 
 
Protein purification and labeling  
Most yeast Arp2/3 complexes were purified using an ammonium sulfate cut, a 
GST-N-WASP-VCA affinity column, and a gel filtration step, as previously described (4, 
5). The Arp3ΔC complexes were an exception, since they could not be eluted from a 
GST-N-WASP-VCA affinity column using high salt, as in the standard procedure. 
Therefore, we eluted Arp3ΔC complexes with a 50 mM reduced glutathione solution, 
then ran the complex through a MonoQ (GE Healthcare) column and a glutathione 
sepharose column to remove the GST-N-WASP-VCA. Pooled fractions were 
concentrated and loaded on a Superdex 200 (GE Healthcare) gel filtration column as the 
final polishing step. The CA-fusion complexes also required modifications of the 
purification protocol. Specifically, wild type complexes were loaded onto the affinity 
column in PKME buffer (25 mM PIPES pH 7.0, 50 mM KCl, 3 mM MgCl2, 1 mM 
EGTA, 100 µM ATP, 1 mM DTT), washed with PKME followed by 275 mM KCl 
PKME, and eluted with either a gradient of 275 mM KCl PKME to QB buffer (20 mM 
Tris pH 8.0, 1 M NaCl, 3 mM MgCl2, 1 mM EGTA, 100 µM ATP, 1 mM DTT) or a step 
elution of high magnesium buffer (25 mM PIPES pH 7.0, 25 mM KCl, 200 mM MgCl2, 1 
mM EGTA, 100 µM ATP, 1 mM DTT).  In contrast, CA-fusion complexes were loaded 
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in 25 mM KCl PKME and the high salt PKME wash was omitted. Elution was 
accomplished with a gradient of PKME containing 25 mM to 500 mM KCl. The affinity 
column elutions for CA-fusion preparations were passed through MonoQ and gel 
filtration columns. For all complexes used in crosslinking assays, the gel filtration and 
final storage buffer lacked reducing agent.  Complexes were concentrated to ~5-25 µM in 
Vivaspin Turbo 15 centrifugal concentrators (50K MWCO, Sartorius Stedim Biotech) 
and flash frozen within hours of the final gel filtration step. Flash freezing did not 
influence the activity of any of the purified complexes in pyrene actin polymerization 
assays.  
To purify crosslinked complex, the dual cysteine complex was isolated using the 
standard (wild type) protocol and gel filtered in KMEI buffer + ATP (10 mM Imidazole 
pH 7.0, 50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 200 µM ATP). Pooled fractions were 
diluted to 1 µM. 5 µM LZ-N-WASP-VCA was added to the mixture and crosslinking 
was initiated by adding 10 µM BMOE and reacting for 1 hour at room temperature. The 
reaction was quenched with 1 mM DTT and the reaction mix was passed over a MonoQ 
column (20 mM PIPES pH 7.0, 50-500 mM NaCl, 1 mM DTT) to separate LZ-N-WASP-
VCA. Fractions containing Arp2/3 complex were pooled and dialyzed into GST-Dip1 
binding buffer (25 mM Tris pH 8.0, 50 mM KCl, 1mM MgCl2, 100 µM ATP, 1 mM 
DTT). A Dip1 affinity column was prepared by passing ~10 mg of previously frozen 
GST-Dip1 on a 5 mL GSTrap FF column (GE life sciences) equilibrated with GST-
binding buffer (20 mM Tris pH 8.0, 140 mM NaCl, 1 mM EDTA) and then washed with 
GST-Dip1 binding buffer. The crosslinking reaction mixture was loaded on the column at 
a flow rate of 0.25 mL/min, washed with 10 column volumes GST-Dip1 binding buffer 
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and eluted with the same buffer containing 500 mM KCl. Eluted fractions containing 
pure crosslinked Arp2/3 complex were pooled and dialyzed into storage buffer (20 mM 
Tris pH 8.0, 50 mM NaCl, 1 mM DTT) before concentrating and flash freezing.  Please 
see supplemental material for description of purification of actin and NPF proteins, as 
well as protocols for biochemical assays. 
 
Construction of fission yeast strains 
A fission yeast strain harboring the arp3ΔC(416-427) mutation was made by 
transforming the TP150 strain with a cassette harboring a premature stop codon and the 
KanMX6 marker as described (6). The integrated mutant gene was confirmed by 
amplifying and sequencing the region. See Table S6 for list of fission yeast strains used 
in this study. 
 
Construction of bacterial expression plasmids  
Bos taurus N-WASP-VCA(C431A)(428-505) , LZ-N-WASP-VCA(C431A)(428-505), and N-
WASP-CA(467-505), human WASP-VCA(429-502) and WAVE1-VCA(485-559) and budding 
yeast Las17-VCA(529-633) were each subcloned into the vector pGV67 as GST-TEV-fusion 
constructs. The L471A, R478K, V468C, T464C and ΔDEDED mutations were 
introduced into Bos taurus N-WASP-VCA(C431A) by the Quick Change PCR protocol. 
 
Protein purification and labeling  
Pyrene labeled rabbit skeletal muscle actin, N-WASP-VCA(C431A)(428-505), LZ-N-
WASP-VCA(C431)(428-505), N-WASP-CA(467-505),  WASP-VCA(429-502),  WAVE1-
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VCA(485-559),  Las17-VCA(529-633), Wsp1-VCA(497-574) and GST-Dip1 were purified as 
previously described (4, 7-9). Briefly, constructs were expressed as GST-TEV-fusion 
constructs in BL21(DE3) E.coli cells and isolated using GS4B resin (GE Healthcare) 
following lysis. Constructs were eluted from the column using 50 mM reduced 
glutathione, and the GST tag was cleaved with TEV protease overnight. Cleaved 
constructs were isolated by passing through a Source30Q column followed by gel 
filtration on a Superdex 75 column (GE Healthcare). All constructs used in crosslinking 
assays were either stored in buffer lacking DTT or dialyzed prior to crosslinking 
reactions to remove DTT. N-WASP-VCA(C431A, T464C) was labeled with 
benzophenone-4-maleimide (B4M) and SpWsp1-VCA was labeled with rhodamine as 
previously described (7).   
 
Pyrene actin polymerization assays and kinetic data analysis  
Pyrene actin polymerization assays were carried out by adding 1 µL of 100X antifoam 
(100X: 0.005% Antifoam-204, Sigma) and 2 µL of 10X ME buffer (10X: 5 mM MgCl2, 
20 mM EGTA) to 20 µL of a 5X actin stock and incubated for 2 minutes to exchange 
calcium from G-buffer to magnesium. To initiate polymerization, 77 µL of buffer, salts, 
Arp2/3 complex and NPFs were added to bring the final concentrations to 10 mM 
Imidazole pH 7.0, 50 mM KCl, 1 mM EGTA, 1 mM MgCl2, 200 µM ATP and 1 mM 
DTT. Polymerization was monitored by exciting the sample at 365 nm and monitoring 
the emission at 407 nm using a Tecan Safire 2 plate reader. The maximum rate of 
polymer formation was calculated by determining the maximum slope from each curve 
and converting RFU/s to nM/s by using the equation below, where the concentration of 
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polymer is the equilibrium concentration, equal to the total concentration of actin minus 
0.1 µM: 
 
 
The concentration of barbed ends was calculated by the following equation: 
 
 
 
Where 11600 nM-1s-1 is the previously determined barbed end assembly rate (10). Time 
to half-maximal polymerization was calculated by determining the time point where the 
fluorescence equaled the average of the maximum and minimum fluorescence units for 
every curve.  
 
Short pitch crosslinking assays 
In a typical short pitch crosslinking assay, 16 µL of a solution containing Arp2/3 complex 
with or without additional components (e.g, ATP or NPF) in KMEI was mixed with 4 µL 
of 125 µM BMOE in water for one minute before adding 80 µL 1.25x SDS-PAGE 
loading buffer (1x SDS-PAGE buffer: 0.3 % SDS, 33 mM DTT, bromophenol blue). For 
experiments in figure 3, wild type complex was dialyzed into KMEI buffer without DTT 
prior to crosslinking and reactions were quenched with 1 mM DTT before running 
polymerization assays. All replicates for comparison of different conditions within a 
given panel in the manuscript were run in a single set of reactions on the same day to 
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reduce variability. Reactions were run on SDS-PAGE and transferred to nitrocellulose 
membranes. For single color western blots, membranes were treated with goat anti-Arp3 
(Santa Cruz, sc-11973, 1:1000 dilution) followed by donkey anti-goat IRDye 680RD 
(LICOR, 1:10000 dilution). For two color blots, goat anti-Arp2 (Santa Cruz, sc-11969, 
1:1000 dilution) and mouse anti-Arp3 (Santa Cruz, sc-376625, 1:1000 dilution) were 
simultaneously incubated followed by donkey anti-goat IRDye 680RD and donkey anti-
mouse IRDye 800CW (LICOR, 1:10000 dilution). Blots were scanned and quantified 
using a LICOR Odyssey Fc imaging system. Truncation of the Arp3 C-terminus exposed 
at least one endogenous cysteine on Arp3 (Cys 426), resulting in formation of an 
additional crosslinking product that complicated our analysis (Fig. 8D). To reduce 
crosslinking with endogenous cysteines, we created an Arp3ΔC(C426A) mutant in the 
context of the engineered dual cysteines.  
 
B4M crosslinking reactions 
B4M crosslinking reactions were carried out by mixing 1.5 μM Arp2/3 complex with 4 
μM N-WASP-VCA(T464C-B4M) in KMEH buffer (10 mM HEPES pH 7.0, 50 mM 
KCl, 1 mM MgCl2, 1 mM EGTA, 200 µM ATP) with and without 100 μM LZ-VCA. 
Reactions were illuminated with a UV transilliminator equipped with 350nm bulbs for 10 
minutes at 4 °C. Reaction products were separated by SDS-PAGE, transferred to 
nitrocellulose membranes and blotted with either goat anti-Arp2 (Santa Cruz, sc-11969, 
1:1000 dilution) or goat anti-Arp3 (Santa Cruz, sc-11973, 1:1000 dilution) followed by 
donkey anti-goat IRDye 680RD (LICOR, 1:10000 dilution). 
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Analysis of crosslinking distances 
To investigate the crosslinking distance between the engineered cysteines in the 
trajectory from the splayed to the short pitch conformation, we first generated structural 
morphs from the splayed to short pitch state using Pymol. For the splayed conformation 
we used the crystal structure of Bos taurus Arp2/3 complex with bound GMF (GMF was 
not included in the morph) (11), as this is the only high resolution Arp2/3 complex crystal 
structure in which nearly all of Arp2 is ordered. For the short pitch conformation we used 
either the branch junction EM model, or a model constructed using the cryoEM structure 
of an actin filament (3G37) as a short pitch template. An actin subunit from 3G37 was 
overlaid onto subdomains 1 and 2 of Arp3 in 4JD2, then Arp2 from 4JD2 was superposed 
onto the actin in the short pitch position. Modeled structures along each of the two 
trajectory were input into Xwalk, a program that calculates the solvent accessible surface 
distance between crosslinkable residues (3). In contrast to the Euclidian distance, this 
calculation accounts for the fact that crosslinkers cannot pass through sterically occluded 
space.  
 
CuSO4 crosslinking assays 
Copper sulfate crosslinking assays were carried out by mixing 0.5 μM wild type, 
Arp3ΔC, or Arp3ΔC(C426A) S. cerevisiae Arp2/3 complex with 2 μM N-WASP-
VCA(V468C) in buffer containing 50 μM CuSO4,10 mM Imidazole pH 7.0, 50 mM KCl, 
50 μM EGTA, 1 mM MgCl2 and 200 µM ATP. Some reactions also contained 50 μM N-
WASP-CA. After incubation for 1 hr at room temperature, samples were mixed with 
SDS-PAGE loading buffer containing 2 mM N-Ethylmaleimide and no reducing agent 
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before separation by SDS-PAGE. The Arp2/3 complexes used in these crosslinking 
assays did not contain the engineered short pitch crosslinking cysteines. 
 
 
Actin filament copelleting assays 
100 nM short pitch crosslinked Arp2/3 complex with or without 20 µM N-WASP-CA 
were incubated for 20 minutes with 5 µM pre-formed actin filaments in a final volume of 
50 µL. Reactions were spun in a TLA100 rotor (Beckman Coulter) at 85K rpm for 15 
minutes. Supernatant was removed and transferred to a fresh tube and 10 µL of 6x SDS-
loading buffer was added to bring the final volume to 60 µL. Pellets were dissolved with 
60 µL of pre-warmed 1x SDS-loading buffer and then samples were resolved by SDS-
PAGE followed by western blot analysis using goat anti-Arp3 (Santa Cruz, sc-11973, 
1:1000 dilution) and donkey anti-goat IRDye 680RD (LICOR, 1:10000 dilution). 
 
Fluorescence anisotropy binding assays 
The fluorescence anisotropy of a mixture of 75nM Rhodamine-labeled SpWsp1-VCA, 2 
μM wild type or 1.5 μM Arp3ΔC S. pombe Arp2/3 complex in KMEI (10 mM Imidazole 
pH 7.0, 50 mM KCl, 1 mM EGTA, 1 mM MgCl2, 200 µM ATP, 1 mM DTT) was 
measured using an ISS PC1 fluorometer.  The excitation wavelength was 557 nm and 
emission wavelength was 574 nm. Arp2/3 complex was sequentially diluted by removing 
a portion of the reaction and then diluting it with the same volume of an identical solution 
lacking Arp2/3 complex. The fluorescence anisotropy was measured for a range of 
Arp2/3 complex concentrations. Because the two WASP-CA sites show an approximate 
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ten-fold difference in binding affinity in other Arp2/3 complexes tested, we assumed that 
under the conditions of the assay, only binding to the high affinity site contributes 
significantly to the anisotropy change (12, 13). The data were fit to the single-site binding 
equation below: 
 
 
 
Where LB and LF are the anisotropy values of fully bound and free Rho-Wsp1-VCA, 
respectively, and LT is the total Rho-Wsp1-VCA concentration. Competition binding 
assays with unlabeled Wsp1-VCA were performed by measuring the anisotropy of 15 μM 
Wsp1-VCA with 75 nM Rho-Wsp1-VCA and 500 nM wild type or 300 nM Arp3ΔC 
Arp2/3 complex. Wsp1-VCA was diluted using an identical buffer lacking Wsp1-VCA. 
Competition binding data sets were fit as described by Wang (14). 
 
 
 
Table S1: Table of p values for Figure 2C. 
n.s. = non-significant. p-values calculated as two-tailed t-test comparing means of at least 
three experiments. 
  N-WASP-VCA WASP-VCA WAVE1-VCA Las17-VCA N-WASP-CA 
  1μM 20μM 30μM 1μM 20μM 30μM 1μM 20μM 30μM 1μM 20μM 30μM 30μM 50μM 
Arp2/3 
alone 
 0.0005
0 
p<0.000
1 
p<0.000
1 
p<0.000
1 
p<0.000
1 
0.0001
3 0.0011 
0.001
9 
0.0002
2 
0.004
4 
0.001
5 
0.0001
4 
p<0.000
1 
p<0.000
1 
N-
WASP
-VCA 
1μM  
0.0003 0.00019 n.s. 0.0019 0.0022 n.s. 0.034 0.0033 n.s. 0.012 0.0013 0.0018 
p<0.000
1 
20μM   
n.s. 0.00017 0.016 n.s. 0.00013 0.031 n.s. 
0.004
8 n.s. n.s. n.s. n.s. 
30μM    p<0.000
1 0.031 n.s. 
p<0.000
1 n.s. n.s. 
0.006
5 n.s. n.s. n.s. 0.016 
WASP
-VCA 
1μM     
0.0011 0.0015 0.022 0.032 0.0025 n.s. 0.012 0.0010 0.0015 
p<0.000
1 
20μM      n.s. 0.00061 n.s. n.s. 0.039 n.s. n.s. 0.047 0.0014 
30μM       0.00081 n.s. n.s. 0.027 n.s. n.s. n.s. 0.0068 
WAVE
1-VCA 
1μM        
0.012 0.0013 n.s. 0.006 
0.0006
1 0.00090 
p<0.000
1 
20μM         n.s. n.s. n.s. n.s. 0.047 0.0052 
30μM          0.034 n.s. n.s. n.s. 0.0078 
Las17-
VCA 
1μM           0.046 0.0096 0.0094 0.00056 
20μM            n.s. n.s. n.s. 
30μM             n.s. n.s. 
N-
WASP
-CA 
30μM              n.s. 
50μM               
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Table S2: Table of p values for Figure 3B.  
n.s. = non-significant. p-values calculated as two-tailed t-test comparing means of at least 
three experiments. 
 WT WT + 
CA 
Arp2-
CA 
Arp2-CA + 
CA 
Arp3-
CA 
Arp3-CA + 
CA 
WT  p<0.0001 0.0035 p<0.0001 0.0018 p<0.0001 
WT + CA   0.0048 0.046 0.00023 n.s. 
Arp2-CA    0.0019 n.s. 0.00031 
Arp2-CA + 
CA 
    0.00064 n.s. 
Arp3-CA      p<0.0001 
Arp3-CA + 
CA 
      
 
 
Table S3: Table of p values for Figure 6C.  
n.s. = non-significant. p-values calculated as two-tailed t-test comparing means of at least 
three experiments. 
 
NWASP 
(30μM) 
L471A 
(50μM) 
R478K 
(50μM) 
ΔDEDED 
(30μM) 
Arp2/3 + 
ATP 0.00057 0.0065 0.0012 0.00021 
+N-WASP 
(30μM)  0.0042 0.0053 n.s. 
+L471A 
(50μM)   n.s. 0.0022 
+R478K 
(50μM)    0.0033 
+ΔDEDED 
(30μM)     
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Table S4: List of budding yeast expression plasmids used. 
Name Gene Vector Source 
pDW6 ARP2  pRS316 R. Li 
pDW20 ARP3-MYC-HISx6 pRS316 R. Li 
pCE04 ARP2 pRS305 R. Li 
pCE05 ARP3 pRS305 R. Li 
pBN01 ARP2 pRS317 (4) 
pBN02 ARP3 pRS315 (4) 
pBN03 arp2 R198C pRS317 (4) 
pBN09 arp3 L155C pRS315 (4) 
pMR06 arp2-CA, R198C pRS317 
This 
study 
pMR09 arp3∆Cterm440-449, L155C pRS315 
This 
study 
pMR11 arp3-CA, L155C pRS315 
This 
study 
pMR14 
arp3∆Cterm440-449, 
L155C,C426A pRS315 
This 
study 
pMR28 arp3∆Cterm440-449 pRS315 
This 
study 
pMR29 arp3∆Cterm440-449, C426A pRS315 
This 
study 
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Table S5: List of budding yeast strains used.  
Strain Genotype Source 
KEBY88 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, suc2-∆9, pep4-3  T. Stevens 
RLY188 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, ∆arp3::HIS3, pDW20::URA3 R. Li 
“wild type” pep4-3::KAN T. Stevens 
BN002 MATa, ura3-52, his3-Δ200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 pDW6::URA3 (4) 
BN021 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 ∆arp3::HIS3  
pBN09::LEU2  pBN03::LYS2 (4) 
MR001 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pDW20::URA3  This study 
MR008 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::trp1-901, pMR06::LYS2 This study 
MR010 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pBN09::LEU2 This study 
MR012 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR09::LEU2 This study 
MR014 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR11::LEU2 This study 
MR016 MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, pBN03::LYS2 This study 
MR017 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1, ∆arp3::HIS3  
pBN09::LEU2  pMR01::LYS2 This study 
MR019 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 ∆arp3::HIS3 
pBN09::LEU2  pMR03::LYS2 This study 
MR020 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 ∆arp3::HIS3  
pBN09::LEU2  pMR04::LYS2 This study 
MR022 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 ∆arp3::HIS3  
pBN03::LYS2  pMR09::LEU2 This study 
MR025 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::trp1-901 ∆arp3::HIS3  
pBN09::LEU2 pMR06::LYS2 This study 
MR027 
MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::trp1-901 ∆arp3::HIS3  
pBN03::LYS2 pMR11::LEU2 This study 
MR030 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3 pMR14::LEU2 This study 
MR032 
MATa, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp2::TRP1 ∆arp3::HIS3  
pBN03::LYS2, pMR14::LEU2 This study 
MR050 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR28::LEU2 This study 
MR051 MATα, ura3-52, his3-∆200, leu2-3, lys2-801, trp1-901, ∆arp3::HIS3, pMR29::LEU2 This study 
 
 
 
 
Table S6: List of fission yeast strains used. 
Strain Genotype Source 
BN024 leu1-32 sm902 arp3∆416-427::kanMX6 (Submitted) 
TP150 h- leu1-32 sm902 M. Yanagida 
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